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SUMMARY
Group A Streptococcus (GAS) is a human-specific pathogen that evades the host immune response 
through the elaboration of multiple virulence factors. Although many of these factors have been 
studied, numerous proteins encoded by the GAS genome are of unknown function. Herein, we 
characterize a biomimetic red blood cell (RBC)-captured protein of unknown function—annotated 
subsequently as S protein—in GAS pathophysiology. S protein maintains the hydrophobic 
properties of GAS, and its absence reduces survival in human blood. S protein facilitates GAS 
coating with lysed RBCs to promote molecular mimicry, which increases virulence in vitro and in 
vivo. Proteomic profiling reveals that the removal of S protein from GAS alters cellular and 
extracellular protein landscapes and is accompanied by a decrease in the abundance of several key 
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GAS virulence determinants. In vivo, the absence of S protein results in a striking attenuation of 
virulence and promotes a robust immune response and immunological memory.
In Brief
Wierzbicki et al. show that S protein is a major group A Streptococcus (GAS) virulence factor that 
facilitates bacterial coating with lysed red blood cells to promote molecular mimicry, which 
increases virulence in vitro and in vivo. Removal of S protein reduces the abundance of multiple 
virulence factors and attenuates virulence.
Graphical Abstract
INTRODUCTION
Streptococcus pyogenes (group A Streptococcus [GAS]) is a leading health and economic 
burden worldwide, with an estimated 700 million infections occurring annually. Among 
these are 18.1 million severe cases that result in over 500,000 deaths (Carapetis et al., 2005). 
Despite active research, a protective vaccine remains elusive (Dale et al., 2016; Rivera-
Hernandez et al., 2016), leaving antimicrobial agents as the sole pharmacological 
intervention against GAS. To date, penicillin remains a primary drug of choice for 
combating GAS infections. However, despite no apparent emergence of resistant isolates, 
the rate of treatment failures with penicillin has increased to nearly 40% in certain regions of 
the world (Brook, 2013). Due to the high prevalence of GAS infection and the decreasing 
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efficacy of the available repertoire of countermeasures, it is critical to investigate alternative 
approaches against GAS infection.
An emerging strategy for combating drug-resistant bacteria involves targeting virulence 
(Allen et al., 2014; Baron, 2010; Rasko and Sperandio, 2010). GAS has evolved to readily 
colonize and thrive within the human host. To avoid immune clearance, GAS expresses a 
wide variety of secreted and cell-associated virulence factors to facilitate survival during 
infection. The pantheon of these virulence factors is extensive, and some such as 
Streptolysin S have been studied for over 100 years (Molloy et al., 2011). Despite decades of 
inquiry into the role and regulation of GAS virulence factors, the function and potential 
importance of many proteins involved in pathogenicity remain unknown.
To facilitate the exploration of virulence factors, our group recently developed Biomimetic 
Virulomics, a tool that uses nanotechnology-enabled affinity enrichment coupled with 
multiplexed quantitative proteomics. This tool successfully enriched red blood cell (RBC)-
specific effector proteins secreted by GAS (Distler and Tenzer, 2017; Lapek et al., 2017a). 
Among the identified proteins were known blood toxins, such as Streptolysin O and CAMP 
factor. Also identified were several proteins of unknown function.
Here, we examine one of the previously uncharacterized proteins captured by our RBC-
based Biomimetic Virulomics study, SPy_0802 (henceforth named S protein), and 
investigate its role in GAS pathogenesis. Using an in-frame deletion mutant, Δess, we 
characterized the impact of S protein on GAS physiology, its interactions with human RBCs 
and phagocytic cells in vitro, its role in cellular and extracellular proteome composition, and 
its virulence in an in vivo murine model of disseminated infection. Furthermore, we 
examined host responses through quantitative proteomic analysis of splenic tissues infected 
with wild-type (WT) GAS or the Δess mutant. Because of its pivotal roles in pathogenesis 
and immune evasion and its conserved nature in Streptococci, S protein shows promising 
clinical potential as a target for the development of anti-virulence pharmacological 
interventions.
RESULTS
S Protein Is a Highly Conserved Protein across GAS Serotypes
SPy_0802 was identified through the use of Biomimetic Virulomics, a recently published 
affinity-capture method that uses mass-spectrometry-based proteomics of RBC-coated 
nanoparticles incubated with GAS culture supernatants (Figure 1A) (Lapek et al., 2017a). 
The SPy_0802 locus is highly conserved and largely specific among the members of the 
Streptococcus genus (Figure 1B). SPy_0802 is a relatively small protein composed of an N-
terminal hydrophobic region and a C-terminal peptidoglycan-binding motif, LysM (Figure 
1C). The alignment of SPy_0802 sequences from 20 available GAS strains revealed 99% 
similarity with only 5 variable amino acids (Figure S1A). Due to the high amino acid 
conservation of SPy_0802 among GAS strains and the presence of homologous proteins 
limited to other Streptococcus species, we named this translational product S protein and its 
genetic locus ess.
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S Protein Is an Extracellular and Cell-Wall-Associated Protein
S protein was identified in our original work as a secreted protein (Lapek et al., 2017a), 
although it was detected in a previously published screen for membrane-bound GAS 
antigens (Rodríguez-Ortega et al., 2006). To address these divergent findings, a recombinant 
version of the protein was purified (Figure S1B) and used to raise polyclonal rabbit antisera. 
Immunoblotting analyses indicated that S protein is abundant both as a cell-associated 
protein and in the extracellular milieu throughout GAS growth. In the supernatant, it 
undergoes proteolytic cleavage during stationary phase (Figures 1D and 1E) through a yet-
to-be-determined mechanism.
S Protein Governs Hydrophobic Properties of GAS Cells
To study the effect of S protein on GAS physiology, an allelic exchange deletion strain and a 
complemented deletion strain expressing S protein in trans (Δess pDCerm::ess) were 
constructed in an M1 5448 background. We observed that the absence of S protein resulted 
in a striking difference in cell sedimentation (Figure 1F). We hypothesized that this distorted 
phenotype was related to a difference in cell morphology. We tested this using fluorescence 
microscopy of GAS cells. However, no difference in Δess cell chain length or diameter was 
detected (Figures S1C and S1D). We next sought to determine whether the sedimentation 
defect could be caused by differential proliferation rates caused by the absence of S protein. 
Measured viable cell counts indicated no difference in the Δess growth pattern or generation 
time (G) (Figure 1G). Analysis of GAS growth curves based on the optical density indicated 
that bacteria deprived of S protein are more dispersed in the medium (Figure 1H).
Upon further examination of GAS during growth, it was observed that at a certain density, 
cells expressing S protein form macro-structures (Figure 1I). Over time, these structures 
precipitate in culture. Furthermore, upon disruption, these macro-structures re-formed over 
time (Figure S1E).
Based on the different strain behavior in the culture medium, we hypothesized that 
formation and sedimentation of the cellular macro-structures are driven by the hydrophobic 
properties of the GAS cell surface. To test this, we analyzed GAS sedimentation in media 
with different chemical properties. WT and complemented strains sedimented in the water 
control medium and remained in solution upon addition of the water-miscible solvent 
methanol (Figures 1J and 1K). In contrast, Δess displayed an opposite behavior under these 
test conditions. Finally, we measured the GAS surface hydrophobicity based on the ability of 
cells to bind n-hexadecane (Rosenberg et al., 1980). Our data show that Δess binds less n-
hexadecane than WT and complemented strains (Figure 1L). Spontaneous cell lysis was not 
observed for the above experiments (Figures S1F and S1G).
Δess Is More Susceptible to Phagocytic Killing In vitro
Blood survival and dissemination is a major virulence property of GAS and is achieved 
through several mechanisms (Fischetti, 2016). Because S protein was identified as an RBC-
specific protein, we analyzed its importance for GAS growth in blood. We observed that 
Δess had a significantly decreased ability to grow in human blood compared to the WT and 
complemented strains (Figure 2A). Next, we analyzed the interaction of Δess with individual 
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blood components. S protein was not required for β-hemolysis (Figures 2B and 2C). 
Because S protein is predicted to be peptidoglycan associated, we next endeavored to test 
whether S protein might act as a protective agent against complement killing. The absence of 
S proteins did not affect GAS resistance to complement-mediated killing (Figures 2D and 
S2A). Further probing of the blood components revealed that a lack of S protein results in 
GAS being more readily captured, phagocytized, and killed by THP-1-derived macrophages 
(Figures 2E–2G). We next assessed bacterial viability in the presence of human neutrophils. 
We found that Δess was more susceptible to extracellular killing in the presence of 
neutrophils. In our study of bacterial internalization by neutrophils, there was a trend toward 
increased uptake of Δess compared to WT and complemented strains (Figures 2H and 2I). 
Increased association and phagocytosis of Δess in the phagocytic cells was only marginally 
rescued in the complement strain. Therefore, we subsequently quantified the hyaluronic acid 
capsule, an anti-phagocytic GAS determinant (Wessels et al., 1991). This assay showed 
decreased encapsulation of the complemented strain but not of Δess (Figure 2J). These data 
support the notion that all phagocyte-related phenotypes of Δess are caused by a lack of S 
protein expression, while the elevated amount of complemented strain captured and 
internalized by phagocytes is a consequence of decreased capsule formation.
Binding of RBC Membranes by Surface-Associated S Protein Facilitates GAS Virulence
Because a previous study showed that S protein present in bacterial culture supernatants 
selectively binds to RBC nanosponges (RBCNSs) (Lapek et al., 2017a), we investigated the 
interaction between RBCs and cell-associated S protein. To this end, we tested binding of 
RBCNSs by whole GAS cells. Corroborating previous findings, Δess bound significantly 
less RBCNSs than WT and complemented strains (Figure 2K).
Based on these observations, we hypothesized that S protein coopts host RBC membranes 
for immune camouflage. To test this, we evaluated interactions with macrophages of GAS 
preincubated in RBC solution or PBS. Upon 100% endogenous lysis of RBCs (Figure S2B), 
WT and complemented strains gained a prominent red color, whereas Δess became faintly 
pink, indicating reduced RBC binding in the absence of S protein (Figure 2L). RBC coating 
did not affect GAS viability or the amount of bacteria associating with or surviving within 
macrophages (Figures S2C and 2M). However, pre-incubation with RBCs decreased the 
phagocytic uptake of the WT and complemented strains, while increasing the uptake of 
Δess.
We next tested the effect of RBC coating on GAS survival in whole human blood. 
Supporting our in vitro macrophage data, pre-incubation with RBCs increased the 
proliferation rate of the WT and complemented strains and decreased the viability of Δess 
when compared to bacteria preincubated with PBS (Figure 2N). Finally, we analyzed the 
effect of RBC coating on GAS virulence in vivo by using a mouse model of systemic 
infection (Lapek et al., 2018). In the tested cohort, mortality rates of 40% and 90% were 
observed for mice infected with uncoated and RBC-coated WT GAS, respectively (Figure 
2O). Furthermore, the majority of the animals infected with GAS preincubated with RBCs 
displayed a more rapid decrease in body weight (Figure2P;TableS1).
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Absence of S Protein Reshapes GAS Cellular and Extracellular Proteomes
To gain a more comprehensive understanding of the role S protein plays in GAS physiology, 
we performed a quantitative proteomic analysis of WT, Δess, and complemented strain 
whole-cell lysates and culture supernatants (Figure 3A). Whole-cell lysate analysis revealed 
several differentially abundant proteins as follows: 203 between WT and Δess, 90 between 
WT and complemented, and 185 between complemented and Δess (Figure 3B; Table S2). 
Results from the culture supernatant proteome analysis were even more striking, with 
numbers of proteins showing altered expression as follows: 305 between WT and Δess, 19 
between wild and complemented, and 352 between complemented and Δess (Figure 3C; 
Table S2). We excluded from further analysis proteins that were either similarly 
dysregulated in Δess and complemented strains in comparison to the WTstrain or 
exclusively altered in the complemented strain (with exception to S protein). Through the 
comparison of Δess to the WT and complemented strain, we defined a core set of 94 and 236 
cellular and extracellular proteome components affected by S protein, respectively (Figures 
3D and 3E). The vast remodeling of the proteome landscape in Δess is may be at least in part 
driven by the change in expression of four putative transcription factors, although this 
hypothesis requires further investigation.
Classification of S-protein-dependent proteins revealed that they belong to multiple 
functional categories, although most were uncharacterized (Figures 3D and 3E). Notably, in 
the absence of S protein, many recognized virulence factors critical for invasive disease were 
downregulated in bacterial cells and culture supernatants (Figures S3A and S3B).
Among the virulence factors downregulated in Δess was M protein, a widely studied and 
highly abundant GAS virulence factor (Fischetti, 2016). Several studies have demonstrated 
the role of M protein in GAS surface hydrophobicity and bacterial aggregation (Frick et al., 
2000; Tylewska et al., 1979). Because our data show that Δess displays defects in cell 
sedimentation and surface hydrophobicity (Figures 1F and 1I–1L), we investigated whether 
these phenotypes were related to downregulation of M protein or whether they were S 
protein specific. We introduced into Δess a vector containing the emm1 gene under the 
control of a constitutive promoter (pDCerm::emm1) to elevate M protein abundance (Figure 
S3C).
The Δess pDCerm::emm1 showed significantly increased amounts of sedimented cells 
compared to Δess, although this strain did not rescue sedimentation to the level of Δess 
pDCerm::ess. This suggests that both S and M proteins play a role in sedimentation (Figure 
S3D). Similarly, elevating M protein abundance in Δess drastically decreased the amount of 
non-sedimented cells remaining in solution (Figure S3E). Because no difference in viability 
was observed among the tested strains (Figure S3F), we concluded that the measurable 
change in cell aggregation is related to M-protein-mediated cell-cell interactions rather than 
differences in bacterial abundance or stage of growth. Subsequent studies showed that 
increased abundance of M protein did not affect n-hexadecane binding by Δess (Figure 
S3G). We conclude that downregulation of M protein affects Δess cell aggregation but not 
surface hydrophobicity.
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Given the large-scale proteome reorganization in the Δess strain, we next investigated the 
hypothesis that S protein bears direct responsibility for binding RBC membranes. To test 
this, we used serum harvested from S-protein-immunized rabbits to pre-block WT GAS 
cells. Compared to bacteria blocked with serum collected from naive rabbits, GAS 
preincubated in anti-S protein serum bound less RBC membranes (Figures S3H and S3I). 
Endogenous hemolysis and recovered bacterial CFUs were equivalent between bacteria 
preincubated in naive and anti-S protein sera (Figures S3J and S3K). Based on these data, 
we conclude that S protein bears a degree of direct responsibility for binding RBC 
membranes.
Δess Mutant Has Highly Attenuated Virulence in a Mouse Model of Systemic Infection
Because Δess displayed a clear decrease in virulence in vitro, we hypothesized that S protein 
plays an important role during infection in vivo. To test this, we used a mouse model of 
systemic infection (Lapek et al., 2018; Lin et al., 2015). During a 10-day trial, WT GAS was 
associated with a progressive decrease in animal body weight and 90% mortality rate 
(Figures 4A and 4B). In contrast, all mice infected with Δess survived the challenge and 
their body weight stabilized and remained constant after a slight initial decline. Dissection of 
animals at day 4 post-infection revealed that Δess was largely cleared from the bloodstream 
(Figure 4C). There was also an overall lower bacterial load in their organs compared to WT 
GAS. The S-protein-complemented strain was also included in the in vivo experiments. 
However, due to poor maintenance of pDCerm::ess vector, no significant difference between 
the complemented strain and Δess was observed in vivo (Figures S4A–S4D).
Subsequent analyses of GAS load throughout the initial days of infection revealed that 24 h 
following infection there were approximately equivalent levels of the WT and Δess GAS 
detected in the blood and splenic tissues (Figures 4D and 4E). Although levels of WT GAS 
in the blood increased almost logarithmically over the course of the subsequent 3 days, the 
amount of Δess increased only slightly by day 3 and began to decline at day 4. Bacterial load 
of WT GAS in the spleens also increased over time, whereas levels of Δess remained similar 
throughout the infection. We also observed that during infection, the spleens of animals 
infected with WT and Δess were significantly enlarged in comparison to control animals 
(Figure 4F). To ensure that the striking in vivo attenuation phenotype observed in Δess was 
not associated with any unexpected mutations garnered during the generation of this strain, 
whole-genome sequencing was performed. This analysis did not reveal any mutations in 
emm1 or other known virulence factors downregulated in the Δess proteome data, including 
known master regulators of GAS virulence (Churchward et al., 2009; Graham et al., 2002; 
Manetti et al., 2007; Metzgar and Zampolli, 2011; Sumitomo et al., 2013).
S Protein Deficiency Leads to Elevated Immune Pathway Signaling and Is Associated with 
Robust Learned Immunity
The spleen is an important secondary lymphoid organ responsible for coordinating innate 
and adaptive immune responses against bacterial pathogens filtered from the blood (Bronte 
and Pittet, 2013). Based on the dynamics of WT and Δess bacterial burden in the blood and 
spleens over the course of infection, we hypothesized that the absence of S protein alters the 
host immune response. To better understand differential immune responses associated with 
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infection with the WT and mutant strain, we performed a tandem mass tag (TMT)-based 
temporal proteomic analysis of spleens harvested from WT, Δess, or PBS mock-infected 
mice on days 1 through 4 post-infection (Figure 5A; Table S3). Upon batch adjustment, the 
proteome data clustered largely by treatment group (Figure 5B). Short Time-series 
Expression Miner (STEM) clustering was used to identify temporal trends in spleen 
proteomics data (Figure S5A; Table S4) (Ernst and Bar-Joseph, 2006).
STEM clustering of Δess spleen proteome data demonstrated one group of proteins that 
appeared to increase in abundance over time (cluster 7). The upward trend of these proteins 
appeared to be largely absent during WT or mock infection (Tables S3 and S4). We next 
subjected the proteins within these clusters to interaction network analysis using String, 
focusing on protein abundance differences between WT and Δess infection cohorts at day 1. 
String analysis revealed a cluster of related proteins involved in antimicrobial activity or 
immune modulation (Figure 5C).
In the Δess infection clusters, we also identified two groups of proteins that began at high 
levels on day 1 and showed a sustained decrease in abundance over time (clusters 0 and 1). 
We found that this protein abundance trend was unique to Δess and that mice infected with 
WT GAS or administered PBS did not show striking changes in these proteins over the 
infection time course, including at day 1 (Tables S3 and S4). As expected, String analysis 
revealed multiple immune-related protein clusters. The most prominent included several 
type I interferon (IFN)-response proteins. Many of these proteins followed the temporal 
trend seen in clusters 0 and 1, spiking on day 1 of Δess infection, and then dropping to levels 
found in the mock-infected animals (Figure S5C). Notably, bacterial burden in blood and 
spleens at day 1 post-infection was roughly equivalent between WT and Δess-infected 
animals (Figures 4D and 4E). The observed pattern of IFN signaling closely matched 
clearance of Δess during infection (Figure 4D). These results suggested that during exposure 
to lethal levels of GAS, IFN signaling is partially responsible for the positive outcomes 
associated with infection with Δess. To test whether type I IFN signaling was responsible for 
enhanced survival of Δess-infected mice, we infected Ifnar1−/− mice with Δess and 
monitored survival for 3 weeks. Whereas earlier studies demonstrated 100% survival of mice 
infected with Δess (Figure 4B), only 38% of Ifnar1−/− mice survived infection with Δess 
(Figure 5E).
Because we saw robust engagement of core immune pathways during the early stages of 
infection with Δess, we hypothesized that infection with a strain lacking S protein might 
elicit long-term immune memory. To test this, we exposed mice to systemic infection with 
Δess or PBS. After 3 weeks, equal numbers of mice from each group were administered PBS 
or infected with WT GAS. Mice initially injected with PBS and later infected with WT GAS 
displayed high mortality (90%) and a decrease in body weight throughout infection (Figures 
5F and 5G). In contrast, 7 out of 8 mice initially exposed to Δess survived the challenge with 
the WT strain and showed no progressive loss in body weight. Collectively, we show that 
infection with Δess stimulates IFN signaling and that challenge with this strain results in 
robust protection against GAS infection.
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DISCUSSION
Despite decades of research and rapid technological advancements, our understanding of 
bacterial physiology and host-pathogen interactions remains limited. Protein products of 
approximately 50% of bacterial genes are either hypothetical or of unknown function 
(Sivashankari and Shanmughavel, 2006). Understanding how these uncharacterized proteins 
affect bacterial pathogenicity is critical for the formulation of alternative pharmacological 
interventions, which is increasingly important in the era of wide-spread antibiotic resistance 
(Zaman et al., 2017). In this work, we have performed an initial characterization of S 
protein, a previously uncharacterized protein, and investigated its involvement in GAS 
pathogenesis.
Pathogens apply a multitude of mechanisms to avoid recognition by the host immune 
system. Imitation of host structures, known as the molecular mimicry, is one such strategy 
(Wessels et al., 1991). Herein, we described a form of molecular mimicry where GAS uses S 
protein to bind RBC fragments. Sequestration of RBC fragments prevents phagocytosis of 
GAS by macrophages and amplifies virulence in vitro and in vivo (Figures 2M–2P). GAS 
hemolysis has been intensively studied. However, the evolutionary rationale behind this 
process remains incompletely understood. The discovery that GAS utilizes lysed RBCs as 
immune camouflage provides a link between hemolysis, a hallmark diagnostic phenotype of 
GAS in the clinical laboratory, and an infectious process of the pathogen.
Proteomic profiling of Δess indicated that the absence of S protein results in a vast 
rearrangement of the GAS cellular and extracellular proteome. These results suggest that S 
protein is a multifunctional protein that, besides directly participating in virulence, could be 
additionally involved in gene expression regulation or in maintaining proteome homeostasis. 
Protein moonlighting, wherein a single protein performs more than one function, is well 
recognized in the literature (Jeffery, 1999, 2003, 2014). Among proteins downregulated in 
Δess were several known virulence factors, including M protein (Table S2; Figures S3A and 
S3B). M protein is a crucial virulence determinant of GAS required for survival in whole 
human blood and avoidance of phagocytosis (Fischetti, 2016). Diminished levels of M 
protein could explain increased susceptibility to in vitro phagocytic killing of the Δess strain 
in the absence of RBC coating (Figures 2E and 2I).
We observed that during early Δess bacteremia, rapid disease clearance was associated with 
a distinct spike in IFN-regulated proteins early in infection (Figures 4D, 4E, and 5D). We 
showed that IFN signaling was necessary for Δess bacterial clearance (Figure 5E). 
Subsequently, it was found that Δess infection was associated with protection from 
reinfection with WT GAS (Figures 5F and 5G). It was previously shown that GAS 
stimulates production of type I and II IFN in human and murine cells and that Ifnar−/− mice 
more readily succumb to GAS infection than WT mice (Cavaillon et al., 1982; Goldmann et 
al., 2007; Gratz et al., 2011; Hyland et al., 2009; Miettinen et al., 2000; Müller-Alouf et al., 
1997). In this study, WT GAS infection was not associated with a spike in IFN levels on 
days 1–4 post-infection. Although inhibition of IFN signaling was not investigated as a GAS 
virulence strategy, our results suggest that robust GAS infection is associated with low 
viability of this immune pathway.
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Together, the findings regarding S protein reported in this work can have a 2-fold impact on 
the development of countermeasures against GAS. First, due to its highly conserved nature 
among GAS serotypes and involvement in virulence, S protein is an ideal target for anti-
virulence therapeutics. Inactivation of S protein function would make GAS vulnerable to the 
host immunity. Second, we identified immune pathways that are strongly associated with 
positive outcomes against GAS infection. These host factors could be a starting point for 
future investigation into host-centered GAS therapies. Ultimately, our findings on S protein 
suggest that key presumptions regarding GAS infectious disease pathogenesis may be 
incomplete and require reevaluation.
STAR★METHODS
LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents including engineered bacterial 
strains should be directed to and will be fulfilled by the Lead Contact, David J. Gonzalez 
(djgonzalez@ucsd.edu). All unique/stable reagents generated in this study are available from 
the Lead Contact without restriction.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice—ICR (CD-1) Outbred Mice were ordered from Envigo. Ifnar1 −/− mice were ordered 
from the MMRRC. Animals were housed in a Specific Pathogen-Free facility, with 2–3 
specimens per individually-ventilated cage with aspen chip bedding. All studies using CD-1 
mice used female mice between 6–8 weeks old. Ifnar1 −/− mice were 13 week old females 
ordered from Jackson Laboratories via MMRRC Jax and were housed as described above. 
All animal experiments were performed in accordance with NIH guidelines and approved by 
the Institutional Animal Care and Use Committee (IACUC) of UCSD under protocol 
S09388.
Bacteria—Streptococcus pyogenes M1 5448 (Chatellier et al., 2000) and its derivatives 
were cultured in Todd Hewitt Broth (Spectrum Laboratory Products, Inc.) supplemented 
with 0.2% yeast extract (VWR International, LLC) (THY) or grown on solid THY with 
addition of 1.4% agar (VWR International, LLC) or Mueller Hinton Agar with 5% Sheep 
Blood (Fisher Scientific) statically at 37°C, unless stated otherwise (Gera and McIver, 
2013). Medium for S. pyogenes strains carrying pHY304-ess::cat, pDCerm, pDCerm::ess, or 
pDCerm::ermm1 was supplemented with 2 μg/mL erythromycin (Spectrum Laboratory 
Products, Inc.). Escherichia coli strains NEB 5-alpha, NEB Turbo, and BL21(DE3) (New 
England BioLabs) and its derivatives were cultured in Luria-Bertani (LB) broth (Spectrum 
Laboratory Products, Inc.) at 37°C with aeration (220 rpm) or on LB agar (Core Bio 
Services) at 37°C, unless stated otherwise (Son and Taylor, 2012). The following antibiotics 
were used to supplement growth medium for E. coli: 250 μg/mL erythromycin for strains 
carrying pHY304, pHY304-ess::cat, pDCerm, pDCerm::ess, or pDCerm::ermm1; 50 μg/mL 
kanamycin (BioPioneer) for strains containing N-HisPP-pET-28a(+) or N-HisPP-
pET-28a(+)::ess. Engineered E. coli and S. pyogenes strains were stored by mixing 700 μL 
of the overnight cultures with 300 μL of 50% sterile glycerol (VWR International, LLC) 
(final glycerol concentration 15%) or 600 μL of the overnight cultures with 400 μL of 50% 
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sterile glycerol (final glycerol concentration 20%) respectively. Bacterial stocks were stored 
at −80°C.
Cell Lines—The acute monocytic leukemia THP-1 cells were acquired from American 
Type Culture Collection (ATCC). All cells were cultured in the RPMI 1640 Medium (ATCC 
modification) (Life Technologies Corporation) supplemented with 10% Fetal Bovine Serum 
(USDA Certified, Heat Inactivated) (Core Bio Services) and 0.05 mM 2-mercaptoethanol 
(Life Technologies Corporation) at 37°C in the presence of 5% CO2. Cells were maintained 
at density 4 × 105 − 1 × 106/mL. Differentiation of THP-1 cells into macrophages was 
achieved by supplementing the medium with 25 nM phorbol 12-myristate 13-acetate (PMA) 
(Sigma Aldrich) and is described in the Method Details section.
METHOD DETAILS
Genetic Manipulations of Streptococcus pyogenes (GAS) M1 5448—Wizard 
Genomic DNA Purification Kit (VWR International, LLC) was used for isolation of 
bacterial genomic DNA. Q5 High-Fidelity DNA Polymerase (New England BioLabs) was 
used for amplification of DNA designated for molecular cloning or sequencing purposes. 
QIAGEN Plasmid Mini Kit (QIAGEN, Inc.) and QIAquick PCR Purification Kit (QIAGEN, 
Inc.) were used for purification of plasmid DNA and PCR products, respectively. Quick-
Load® Taq 2X Master Mix (New England BioLabs) was used for analyses of E. coli and 
GAS clones. DNA sequencing was performed at the Retrogen Inc. core. The ess (SPy_0802) 
gene replacement by chloramphenicol resistance cassette (cat) by homologous 
recombination was performed based on a previously described protocol (Le Breton and 
McIver, 2013) with minor changes to preparation of electrocompetent GAS cells (Dunny et 
al., 1991). Primers for amplification and Gibson Assembly of the chloramphenicol resistance 
cassette (cat) flanked by up- and downstream regions of ess (SPy_0802) gene were designed 
using online NEBuilder Assembly Tool (http://nebuilder.neb.com/). Chromosomal DNA of 
M1 5448 was isolated and served as a template for PCR amplification of 500 base pair 
regions directly up- and downstream of the ess locus using primer pairs ess-up-F/ess-up-R 
and ess-down-F/ess-down-R. The cat gene was amplified using pACYC184 (Nakano et al., 
1995) as a DNA template and primers cat-F and cat-R. PCR products were purified and 
assembled with NEBuilder HiFi DNA Assembly Master Mix (New England BioLabs). The 
assembly product was used as a template for amplification of the entire DNA region with 
primer pair ess-cat-F/ess-cat-R. Plasmid pHY304 (Pritzlaff et al., 2001) was PCR amplified 
using primers pHY304-F and pPHY304-R. PCR products were purified, subjected to 
digestion with EagI-HF and HindIII-HF restriction enzymes (New England BioLabs), 
purified, and ligated using Quick Ligation Kit (New England BioLabs). The entire ligation 
product was used for transformation of E. coli NEB Turbo competent cells (New England 
BioLabs), according to the manufacturer’s recommendation. As pHY304 contains a 
thermosensitive origin of replication that replicates at 30°C, the outgrowth of bacteria in 
SOC medium (New England BioLabs) and overnight incubation on solid medium 
supplemented with erythromycin was performed at 30°C. Bacterial colonies were passaged 
onto fresh solid medium and screened for the presence of pHY304-ess::cat by PCR reaction 
with primers pHY304-Ver-F and pHY304-Ver-R (each primer is complementary to the 
vector region approximately 200 base pairs up- and downstream respectively from the 
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insertion site. The DNA template for the PCR reaction was obtained by suspending minute 
amounts of bacterial cells in 30 μL of sterile ddH2O and incubating for 5 minutes at 100°C). 
Plasmid DNA form positively identified bacterial clones was purified and verified by DNA 
sequencing with primers pHY304-Ver-F and pHY304-Ver-R.
Electrocompetent GAS cells were prepared as follows: overnight cultures of M1 5448 
supplemented with 20 mM glycine (Spectrum Laboratory Products, Inc.) were back-diluted 
(1:20) in 150 mL of THY + 20 mM glycine, incubated until they reached OD600 = 0.2–0.4, 
and cooled on ice for 30 minutes. The culture was spun down for 20 minutes at 10,000 × g, 
4°C, and cells were washed three times with ice-cold 0.625 M Sucrose (Sigma Aldrich), 1 
mM MgCl2 ⋅ 6H2O (Fisher Scientific). Cells were finally suspended in 1 mL of 0.625 M 
Sucrose, 1 mM MgCl2 ⋅ 6H2O and 50 μL aliquots were used immediately or stored at 
−80°C. M1 5448 cells were transformed with 10 μg of pHY304-ess::cat by electroporation 
using BioRad Gene Pulser II and Gene Pulser/MicroPulser Electroporation Cuvettes, 0.2 cm 
gap (BioRad) (cooled on ice before application) at the following settings: voltage 1.75 kV, 
resistance 400 Ω; capacitance: 25 μF. Electroporated cells were mixed with 500 μL of THY 
broth and 0.25 M Sucrose, and were transferred to an Eppendorf tube. They were incubated 
at 30°C for 2 hours and plated on solid medium supplemented with erythromycin. Following 
2 days of incubation at 30°C, bacterial colonies were passaged onto fresh agar plates with 
antibiotic and verified for the presence of pHY304-ess-cat as described above for E. coli. 
M1 5448 pHY304-ess::cat was cultured overnight at 30°C in 10 mL of THY broth 
supplemented with erythromycin, serially diluted in PBS (Cell Signaling Technology, Inc.), 
plated (dilutions 10−3 − 10−5) onto solid medium containing erythromycin, and incubated 
overnight at 37°C. On the following day, bacterial colonies with vectors that had integrated 
into the chromosome were inoculated in 10 mL of THY broth supplemented with 
erythromycin, and cultured overnight at 37°C. Frozen stocks were prepared as described 
above. On the following day, bacteria with an integrated pHY304-ess::cat plasmid 
(indicating a single crossover event) were plated onto solid medium without antibiotic 
supplementation and incubated overnight at 30°C. An individual bacterial colony was next 
inoculated in antibiotic-free medium and incubated at 30°C. On the following day, the 
culture was back-diluted (1:1000) in 10 mL of medium without antibiotic and incubated 
overnight at 37°C. The back-dilution and overnight incubation at 37°C was repeated. The 
culture was subsequently serially diluted in PBS and plated (dilutions 10−3 − 10−5) onto 
solid medium without erythromycin. Bacterial colonies were next passaged in parallel onto 
medium with and without erythromycin. Bacterial clones that that did not grow on medium 
supplemented with erythromycin (indicating a double crossover event) were verified by PCR 
(DNA extracted by boiling in water as described above) with the primer pair essDel-Ver-F/
essDel-Ver-R. Primers are complementary to the chromosomal region approximately 700 
base pairs from the beginning and the end of ess gene, and 200 base pairs up- and 
downstream of homologous recombination sites, respectively. Positively identified Δess 
clones were further verified by DNA sequencing of a PCR-amplified 700 base pairs up- and 
downstream region from the allelic exchange site (essDel-Ver-F/essDel-Ver-R primers were 
used for PCR amplification and sequencing).
The deletion of ess was genetically complemented through expression of ess in trans from a 
pDCerm vector (Jeng et al., 2003). The coding sequence of ess with a 319 base pairs 
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upstream region containing predicted transcriptional promoter region(s) by BPROM (http://
www.softberry.com/berry.phtml?topic=bprom&group=programs&subgroup=gfindb) and 
Promoter Prediction by Neural Network (http://www.fruitfly.org/seq_tools/promoter.html), 
and 100 base pairs downstream containing a transcriptional termination site were amplified 
with primer pair ess-F/ess-R. The 3335 base pairs of pDCerm was amplified with primers 
pDCerm-F and pDCerm-R. Both PCR products were purified, treated with KpnI-HF 
restriction enzyme (New England BioLabs), re-purified, ligated as described above, and the 
entire reaction product was used to transform of E. coli NEB 5-alpha competent cells (New 
England BioLabs), according to the manufacturer’s recommendation. Bacterial clones were 
passaged and screened for the presence of pDCerm::ess by PCR with primers pDCerm-Ver-
F and pDCerm-Ver-R. Primer are complementary to the vector region approximately 200 
base pairs up- and downstream form the insertion site, respectively. The DNA template for 
PCR was obtained as described above. Clones of pDCerm::ess were verified by DNA 
sequencing with primers pDCerm-Ver-F and pDCerm-Ver-R. Electrocompetent Δess cells 
were prepared and electroporated with 1 μg of either pDCerm or pDCerm::ess as described 
above. Cells were mixed with 500 μL of THY broth, 0.25 M Sucrose, transferred to an 
Eppendorf tube, incubated at 37°C for 1 hours, and plated on solid medium supplemented 
with erythromycin. Wild-type M1 5448 was simultaneously electroporated with pDCerm. 
GAS clones were verified for the presence of pDCerm vectors by PCR with the primer pair 
pDCerm-Ver-F/pDCerm-Ver-R as described above.
Genetic complementation of ess deletion with emm1 expressed in trans from a pDCerm 
vector was performed in an analogous manner as described above. The DNA region 
encoding the M protein with 20 base pairs upstream including a native ribosome binding site 
and 100 base pairs downstream containing a transcriptional terminator were amplified with 
primers emm1-F and emm1-R. The PCR product was next digested with KpnI-HF enzyme, 
ligated into a PCR amplified pDCerm vector, and introduced into E. coli NEB Turbo 
competent cells. The verified pDCerm::emm1 vector was next used for transformation of 
Δess cells. All primers used can be found in Table S5.
Purification of Recombinant S Protein and Production of Polyclonal Rabbit 
Antibodies—A recombinant version of S protein containing an N-terminal 6 × His-tag was 
obtained by amplification of the DNA region encoding S protein, excluding the start codon, 
with primer pair ress-F/ress-R. The purified 502 base pair PCR product and N-HisPP-
pET-28a(+) (Buffalo et al., 2016) were cleaved with BamHI-HF and EagI-HF restriction 
enzymes (New England BioLabs), re-purified, ligated, and introduced into E. coli NEB 5-
alpha competent cells as described above. Individual bacterial colonies were passaged onto 
fresh solid medium and screened for the presence of N-HisPP-pET-28a(+)::ess by PCR with 
the primers, NHpET28-Ver-F and NHpET28-Ver-R, binding approximately 200 base pairs 
up- and downstream respectively form the insertion site (preparation of the DNA template 
for PCR was performed as described above). The obtained vector, which was verified by 
DNA sequencing with primers NHpET28-Ver-F and NHpET28-Ver-R, was used for the 
transformation of E. coli BL21(DE3) competent cells (New England BioLabs), according to 
the manufacturer’s recommendation.
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For the production of recombinant S protein, overnight cultures of E. coli BL21(DE3) N-
HisPP-pET-28a(+)::ess was back-diluted (1:100) in 200 mL of LB supplemented with 
kanamycin and cultured to OD600 of approximately 0.5. Recombinant protein expression 
was induced through addition of isopropyl β-D-1-thiogalactopyranoside (IPTG) (Omega 
Scientific) to a final concentration of 0.05 mM, and the culture was incubated on a shaker 
overnight at 18°C and 220 rpm. Bacterial cells were harvested by 10 minute centrifugation 
at 6,000 × g at 4°C and stored at −80°C until used.
Affinity purification of recombinant S protein was performed as follows: pelleted E. coli 
BL21(DE3) N-HisPP-pET-28a(+)::ess cells were suspended in 20 mL of lysis buffer 
composed of 20 mM Tris-HCl pH 8.0 (Avantor Performance Materials), 500 mM NaCl 
(Sigma Aldrich), 10 mM imidazole (Sigma Aldrich), 50 mM L-Arginine (VWR 
International, LLC), 50 mM L-Glutamic Acid (Spectrum Laboratory Products, Inc.), and 
0.5% Triton X-100 (Fisher Scientific). The lysis buffer was supplemented with a 1/4 of a 
cOmplete, Mini EDTA-free Protease Inhibitor Cocktail tablet (Roche Diagnostics) and 
lysozyme (BioPioneer) to a final concentration of 1 mg/mL. Samples were incubated on ice 
for 30 minutes followed by 3 cycles of sonication using a Q500 QSonica sonicator (Qsonica) 
equipped with 1.6 mm microtip at an amplitude of 35%. The sonication protocol was as 
follows: 10 s sonication; 10 s break; total sonication time 2 minutes; with 5 minutes 
incubation on ice in between cycles. Samples were subjected to centrifugation at 16,000 × g 
at 4°C to remove cell debris and unbroken cells. Supernatants containing soluble proteins 
were next passed through a 0.22 μm filter (MilliporeSigma) and incubated for 1 hour at 4°C 
with rotation with 1 mL of Ni-NTA agarose (QIAGEN) equilibrated with lysis buffer. 
Subsequently, the sample was loaded onto a Poly-Prep Chromatography Column (Bio-Rad 
Laboratories) and had been washed with 30 mL of wash buffer I (20 mM Tris-HCl pH 8.0, 
500 mM NaCl, 40 mM imidazole, 50 mM L-Arginine, 50 mM L-Glutamic Acid, 0.5% 
Triton X-100) and 10 mL of wash buffer II (20 mM Tris-HCl pH 8.0, 500 mM NaCl, 40 mM 
imidazole, 50 mM L-Arginine, 50 mM L-Glutamic Acid, 0.05% Triton X-100). 
Recombinant S protein was eluted from the Ni-NTA agarose with 4 mL of elution buffer (20 
mM Tris-HCl pH 8.0, 500 mM NaCl, 250 mM imidazole, 50 mM L-Arginine, 50 mM L-
Glutamic Acid). In order to remove all Triton X-100, the sample was incubated for 2 hour 
rotating at room temperature with 1 g of Bio-Beads SM-2 Adsorbent Media (Bio-Rad 
Laboratories) that was initially equilibrated with elution buffer. Samples were separated 
from the adsorbent media by elution through a Poly-Prep Chromatography Column. 
Samples were transferred to dialysis tubing with molecular weight cutoff 6–8 kDa 
(Fisherbrand), and dialyzed against 10 mM Tris-HCl pH 8.0, 100 mM NaCl, 50 mM L-
Arginine, 50 mM L-Glutamic Acid overnight at 4°C. The total concentration of recombinant 
S protein was measured using the DC Protein Assay (Bio-Rad Laboratories).
Rabbit polyclonal Anti-S protein antibodies against recombinant S protein were prepared by 
Pacific Immunology (https://www.pacificimmunology.com/) using a 13-week antibody 
production protocol and two New Zealand White rabbits (Animal Protocol #1 approved by 
IACUC and the NIH Animal Welfare Assurance Program No. A4182–01; US Department of 
Agriculture 93-R-283).
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Growth in THY Broth—To determine growth rates of GAS strains, overnight cultures of 
M1 5448 wt pDCerm, Δess pDCerm, and Δess pDCerm::ess were back-diluted (1:20) in 10 
mL of fresh medium and incubated for 7 hours at 37°C. Cultures were vortexed at each time 
point and optical densities at wavelength 600 nm (OD600) were measured with the use of 
SPECTRONIC 200 Spectrophotometer (Thermo Fisher Scientific). A sample of the culture 
was then serially diluted (10−1 − 10−5) in PBS and 5 μL spotted on solid medium for colony 
forming units (CFU) enumeration (calculated as CFU/mL). Experiments were performed in 
three biological replicates. Bacterial Generation Time (G) was calculated using the equation: 
G = (t /3:3 log b /B), where t = time interval (180 min), B = average number of bacteria at 
the beginning of the exponential phase of growth (2 hour time point), and b = the average 
number of bacteria at the end of the exponential phase of growth (5 hour time point). 
Bacterial cultures were documented by taking pictures with a Nikon D7000 digital camera 
equipped with macro lens.
Fluorescence Microscopy—To visualize the morphology of GAS cells, bacteria from 
late stationary (overnight cultures) or exponential (4 hours of growth post 1:20 back-dilution 
of overnight culture in fresh medium) phase of growth were mixed by vortexing. 6 μl of each 
cell suspension was added to 1.5 μl dye mix composed of 60 μg/mL FM4–64 (Life 
Technologies Corporation), 10 μg/mL DAPI (Sigma Aldrich), and 2.5 μM SYTOX Green 
(Life Technologies Corporation) in 1X T-base (2 g (NH4)2SO4 [Fisher Scientific], 18.3 g 
K2HPO4 ⋅ 3H2O [Fisher Scientific], 6 g KH2PO4 [Fisher Scientific], 1 g C6H5O7Na3 ⋅ 2H2O 
[Fisher Scientific] per 1 L of ddH2O) and transferred onto an agarose pad (20% LB broth, 
1% agarose [Fisher Scientific]). Samples were air-dried under a fume hood (care was taken 
to prevent over-drying). Cells were visualized on an Applied Precision DV Elite optical 
sectioning microscope equipped with a Photometrics CoolSNAP-HQ2 camera. Pictures were 
deconvolved using SoftWoRx v5.5.1 (Applied Precision). Images for figures were prepared 
using FIJI. Bacterial cell diameters from multiple pictures were quantified with CellProfiler 
(Kamentsky et al., 2011) on two separate occasions.
Quantification of GAS Cells Sedimentation in THY Broth—Overnight cultures of 
M1 5448 wt pDCerm, Δess pDCerm, and Δess pDCerm::ess were mixed by vortexing. 3.6 
mL were transferred to 4.5 mL disposable, polystyrene cuvette (Fisher Scientific), and 
mixed with either 400 μL of ddH2O or methanol (Fisher Scientific). Bacteria were mixed by 
pipetting and cuvettes were sealed with parafilm (Bemis Company Inc.). OD600 was 
measured from the side of the cuvette with SPECTRONIC 200 Spectrophotometer every 15 
minutes for a total of 5 hours at room temperature. Bacterial cell sedimentation was 
measured as a “Change in OD600” which was calculated using equation: (T /TO)×100, 
where T = OD600 at the indicated time point, T0 = initial OD600 at time 0. In order to 
determine if spontaneous cell lysis had occurred during the experiment, bacteria were mixed 
by pipetting and OD600 values were recorded at the terminal time point. Experiments were 
performed in three biological replicates.
Binding of Bacterial Cells to n-hexadecane—Surface hydrophobicity of GAS cells 
measured by the ability to adhere to n-hexadecane was performed based on a previously 
described protocol (Ofek et al., 1983; Rosenberg et al., 1980). Overnight cultures of M1 
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5448 wt pDCerm, Δess pDCerm, and Δess pDCerm::ess were harvested by centrifugation 
for 10 minutes at 10,000 × g at room temperature, and pelleted cells were washed twice and 
suspended in PUM buffer (22.2 g K2HPO4 ⋅ 3H20, 7.26 g KH2PO4, 1.8 g urea [Promega 
Corporation], 0.2 g of MgSO4 ⋅ 7H20 [Sigma Aldrich], per 1 L of ddH2O). Next, 2.4 mL of 
the bacterial suspension was transferred into 13 × 100 mm borosilicate glass disposable 
culture tubes (Fisher Scientific) and 0.4 mL of n-hexadecane (Fisher Scientific) was added. 
Bacteria without addition of n-hexadecane were used as controls for spontaneous cell lysis. 
The OD600 was measured from the side of the tube using a SPECTRONIC 200 
Spectrophotometer. Tubes were next vortexed for 3 minutes, allowed to settle for 15 
minutes, and the OD600 of the bottom fraction was measured. Hydrophobic properties of 
bacterial cells are represented by the percentage of bacteria bound to the n-hexadecane, 
calculated using the following formula:((T0 OD600 − T15 OD600) /T0 OD600)×100, where 
T0 OD600 = OD600 value before vortexing and T15 OD600 = OD600 value after vortexing. 
Experiments were performed in three biological replicates.
Growth of GAS in Whole Human Blood—The ability of GAS strains to multiply in 
whole human blood (The Lancefield Bactericidal Assay) was tested using protocol described 
by Lancefield (1957). Briefly, overnight cultures of indicated bacterial strains were back-
diluted (1:20) in 10 mL of fresh medium and incubated for 75 minutes (OD600 ≈ 0.15), 
serially diluted in PBS, and 100 μL of the 10−4 dilution was plated on solid medium (starting 
inoculum). 100 μL of the 10−4 dilution was mixed with 900 μL of freshly drawn, heparinized 
whole human blood in a heparin coated Eppendorf tube (Fisher Scientific) and incubated for 
3 hours while shaking (220 rpm) at 37°C. Bacteria were next 10-fold diluted in PBS and 100 
μL of undiluted and diluted suspension was plated on solid medium. The ability of GAS to 
survive in whole human blood is represented as multiplication factor (M. F.), which was 
calculated using following formula(CFU final /CFU initial). CFU final = CFU/mL after 3 
hours of incubation, CFU initial = CFU in 100 μL of bacterial suspension mixed with the 
blood.
To determine whether RBC membrane-binding molecular mimicry affected GAS 
proliferation in whole human blood, overnight cultures were adjusted to a concentration 2 × 
107 CFU/mL, and 100 μL of bacteria were preincubated with 100 μL of either PBS or 4% 
RBC solution (prepared as described in the Quantitative in vitro hemolytic activity assay 
section; final concentration 2% RBCs) for 1 hour at 37°C. Bacteria were serially diluted in 
PBS and 100 μL of the suspension containing approximately 500 CFUs was plated for exact 
bacterial enumeration or mixed with 900 μL of fresh human blood. The following incubation 
and plating steps were performed as described above. The fold change between the results 
obtained for bacteria preincubated with RBCs and PBS within each biological replicate was 
calculated using the following formula: (RBC −PBS /PBS). In the formula, RBC = results 
for bacteria preincubated in 2% RBC solution and PBS = results for bacteria preincubated in 
PBS. Experiments were performed in three biological replicates.
Quantitative In vitro Hemolytic Activity Assay—The method for quantification of 
GAS strains hemolytic properties was based on previously described protocols (Saroj et al., 
2016; Shin et al., 1999). Overnight cultures of M1 5448 wt pDCerm, Δess pDCerm, and 
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Δess pDCerm::ess were back-diluted (1:20) in 10 mL of fresh medium, incubated at 37°C 
until the mid-exponential phase of growth (4 hours). Cultures were adjusted with THY to 
cell density of 107 CFU/mL. A 2% red blood cell (RBC) suspension was prepared by 
diluting 25 μL of freshly drawn, heparinized whole human blood in 0.5 mL of PBS. The 
solution was subjected to centrifugation for 10 minutes at 1,000 × g, room temperature 
followed by two wash steps with equivalent volumes of PBS. RBCs were finally 
resuspended in 1.25 mL PBS. A 100 μL aliquot of bacteria was mixed with 100 μL of the 
2% RBC suspension in an Eppendorf tube and incubated for 1 hour at 37°C. THY broth 
alone was used as a control for spontaneous RBCs lysis, and THY broth supplemented with 
Triton X-100 (1% final concentration in the mixture with RBC) (VWR International, LLC) 
was used to determine maximum RBCs lysis. Following incubation, tubes were centrifuged 
for 10 minutes at 1000 × g at room temperature, and 100 μL of the resulting supernatant was 
transferred into a flat-bottom 96-well plate (Fisher Scientific). The amount of released 
hemoglobin was quantified by measuring absorbance at 405 nm using a VersaMax Tunable 
Microplate Reader. Experiments were performed on three separate occasions in technical 
duplicate on each occasion.
Bacterial Survival in Normal Human Serum—To measure the survival of GAS strains 
in normal human serum (NHS), overnight cultures of M1 5448 wt pDCerm, Δess pDCerm, 
and Δess pDCerm::ess were back-diluted (1:20) in 10 mL of fresh medium and incubated at 
37°C to the mid-exponential phase of growth (4 hours). Cultures were harvested by 
centrifugation for 10 minutes at 10,000 × g and pelleted bacteria were suspended in PBS to 
cells density of 106 CFU/mL. Bacteria were serially diluted (10−1 − 10−5) in PBS and 5 μL 
spotted (in technical duplicate) on solid medium for CFU enumeration. 100 μL of bacteria 
(105 CFU) was mixed with either 500 μL NHS (Fisher Scientific) and 400 μL PBS (final 
NHS concentration 50%) or 900 μL NHS (final NHS concentration 90%). Heat inactivated 
NHS (hNHS; 30 minutes incubation at 56°C) was used as a control. Bacterial suspensions 
were incubated for 3 hours at 37°C, serially diluted in PBS and spotted (in technical 
duplicates) on solid medium for CFU enumeration as described above. Bacterial survival 
was calculated using the formula (CFU final /CFU initial)×100, where CFU final = average 
CFU/mL after 3 hours of incubation, CFU initial = average CFU in 100 μL of bacterial 
suspension mixed with the NHS. Experiments were performed on three separate occasions.
THP-1-Derived Macrophage Infection—The procedure for GAS infection of THP-1-
derived macrophages was based on a previously-described protocol (O’Neill et al., 2016), 
with several modifications. THP-1 cells were differentiated into macrophages by harvesting 
the desired amount of cells by centrifugation (6 minutes at 150 × g, room temperature), and 
suspending them in complete growth medium supplemented with 25 nM PMA. Cells (105) 
were seeded in 24-well plate (Fisher Scientific) and incubated for 48 hours at 37°C in the 
presence of 5% CO2. Overnight cultures of indicated GAS strains were centrifuged for 10 
minutes at 10,000 × g at room temperature and suspended in RPMI 1640 Medium (ATCC 
modification) supplemented with 10% heat inactivated normal human serum and 0.05 mM 
2-mercaptoethanol to a final concentration of 2 × 105 CFU/mL. Bacterial cells were 
opsonized by incubation for 20 minutes at room temperature. Differentiated THP-1 cells 
were washed once with PBS and 1 mL of the bacterial suspension was added (multiplicity of 
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infection [MOI] of 2). Following 90 minutes of infection at 37°C, extracellular bacteria were 
killed by adding gentamycin (VWR International, LLC) to a final concentration of 150 
μg/mL. At the same time, medium with bacteria from one set of wells was serially diluted 
(10−1 − 10−2) in PBS and the rest of the medium was removed. Macrophages were washed 
three times with PBS, then lysed by adding 1 mL of 0.05% Triton X-100 in PBS solution 
and incubating for 5 minutes at 37°C. The solution was 10-fold diluted in PBS and 5 μL of 
diluted medium and lysed macrophages were spotted on solid medium for CFU enumeration 
in technical duplicate. After 1 hour of gentamycin treatment at 37°C, the medium was 
removed, cells were washed three times with PBS, and fresh medium (RPMI 1640 Medium 
[ATCC modification], 10% heat inactivated normal human serum, 0.05 mM 2-
mercaptoethanol) supplemented with 150 μg/mL gentamycin was added. Cells from one set 
of wells were lysed, as described above, and 10 μL was spotted on solid medium for 
bacterial enumeration in technical triplicate. Macrophages were incubated for 6 hours at 
37°C. At time points 2, 4, and 6 hours cells were lysed as described above and 10 μL was 
spotted on solid medium for bacteria enumeration in technical triplicate. The following 
formula was used to calculate the amount of bacteria associated with macrophages: (T90 
Cells /T90 Cells + T90 Medium)×100. The amount of internalized bacteria was calculated 
using the following formula: (T1G /T90 Cells + T90 Medium)×100. Bacterial survival 
within macrophages at indicated time points was calculated as follows: (TX /T1G)×100. 
Abbreviations in the above formulas are as follows: T90 Cells = average CFU/mL from 
lysed macrophages after 90 minutes of infection (bacteria that were adhered to and 
internalized by macrophages), T90 Medium = average CFU/mL in medium after 90 minutes 
of infection, T1G = average CFU/mL in lysed macrophages after 1 hour of gentamycin 
treatment, TX – average CFU/mL in lysed macrophages at indicated time points following 1 
hour of gentamycin treatment. Experiments were performed on three separate occasions.
To determine whether RBC membrane-binding molecular mimicry affected the interactions 
between GAS and THP-1 derived macrophages, overnight cultures were adjusted to a 
concentration 2 × 107 CFU/mL, and 100 μL of bacteria were preincubated with 100 μL of 
either PBS or 4% RBC solution (prepared as described in the Quantitative in vitro hemolytic 
activity assay section; final concentration 2% RBCs). 100 μL of 4% RBC solution was 
incubated with 100 μL of THY broth or THY broth with Triton X-100 (1% final 
concentration) as a control for RBC lysis. Following 1 hour incubation at 37°C, bacterial 
cells were serially diluted (10−1 − 10−4) in PBS. 5 μL of each dilution was spotted onto solid 
medium for CFU scoring, and undiluted bacteria were harvested by centrifuged for 10 
minutes at 10,000 × g. After centrifugation, supernatants were collected and used for the 
quantitative in vitro hemolytic activity assay (described in the above section) and cells were 
suspended in RPMI 1640 Medium (ATCC modification) supplemented with 10% heat 
inactivated normal human serum and 0.05 mM 2-mercaptoethanol to a final concentration of 
2 × 105 CFU/mL. The following steps were performed as described above. The fold change 
between the results obtained for bacteria preincubated with RBCs and PBS within each 
biological replicate of the experiment was calculated using the following formula: (RBC 
−PBS /PBS). In the formula, RBC = results for bacteria preincubated in 2% RBC solution 
and PBS = results for bacteria preincubated in PBS. Experiments were performed in three 
biological replicates.
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Human Neutrophil Extracellular Killing—Whole blood was isolated from healthy 
donors into heparinized vacutainer tubes (Becton Dickinson). Blood was layered onto 
Polymorphprep (Progen) and subjected to centrifugation at 500 × g for 30 minutes in a 
swing-bucket rotor at room temperature without braking. The neutrophil layer was extracted 
and washed once in 10 mL of Hank’s Buffered Salt Solution (HBSS) (GIBCO) and spun for 
5 minutes at 400 × g. The cell pellet was resuspended in a solution of RPMI (Sigma) 
supplemented with 10% heat-killed normal human serum (Millipore). 1 × 106 cells/mL were 
added to 24 well plates for neutrophil killing studies. Bacteria were opsonized in RPMI 
supplemented in 10% heat killed normal human serum prior to addition to neutrophil 
suspension studies. For extracellular killing studies, bacteria were added to cells at MOI of 1 
and incubated at 37°C for 45 minutes. Following incubation, cells were resuspended and the 
entire volume of the well was subjected to centrifugation at 400 × g for 5 minutes. 
Supernatants were subjected to serial dilution from 10−1 to 10−2 and 20 μL was spotted onto 
THY+2 μg/mL erythromycin agar plates for CFU enumeration. Recovered extracellular 
CFU following incubation with primary neutrophils was calculated using the following 
formula: Log2(Recovered CFU /mL /Inoculated CFU /mL).
Human Neutrophil Intracellular Uptake—Neutrophils were isolated as described 
above. Bacteria were incubated with neutrophils at MOI of 2 for 45 minutes at 37°C. 
Extracellular bacteria were killed through addition of 100 μg/mL Gentamycin for 30 minutes 
at 37°C. Neutrophils were resuspended and subjected to centrifugation at 400 × g for 5 
minutes. Cell pellets were lysed in 100 μL of sterile ultrapure water, diluted from 10° to 
10−1, and 20 μL was spotted onto agar plates for CFU enumeration. Recovered intracellular 
CFU following incubation with primary neutrophils was calculated using the following 
formula: Log2(Recovered CFU /mL /Inoculated CFU /mL).
Hyaluronic Acid Capsule Quantification—The amount of hyaluronic acid capsule 
produced by tested GAS strains was determined as described previously (Jin and Pancholi, 
2006). Briefly, a standard curve for determining hyaluronic acid capsule formation was 
prepared. This was achieved by mixing 50 μL of hyaluronic acid sodium salt from 
Streptococcus equi (Sigma Aldrich) 2 mL of chromogenic reagent (20 mg of Stains-all 
[Fisher Scientific] and 60 μL glacial acetic acid [Fisher Scientific] in 100 mL of 50% 
formamide [VWR International, LLC]) and measuring absorbance at 640 nm. A 10 mL 
overnight culture of GAS was harvested by centrifugation for 10 minutes at 10,000 × g at 
room temperature. Pelleted cells were suspended in 0.5 mL of ddH2O. Next, 1 mL of 
chloroform (Fisher Scientific) was added, bacteria were vortexed for 15 minutes, and 
centrifuged for 10 minutes at 12,000 × g at room temperature. 50 μL of the aqueous phase 
was collected, mixed with 2 mL of chromogenic reagent, and absorbance was measured. 
Hyaluronic acid capsule concentration was calculated based on the standard curve as “μg/
mL.” Experiments were performed in biological triplicate.
RBCNS Binding by GAS Cells—Mouse Red Blood Cell (RBC) membrane nanosponges 
(RBCNS) were prepared as described previously (Hu et al., 2015; Lapek et al., 2017a). 
Briefly, 100 nm PLGA polymeric cores were prepared using 0.67 dL/g of Carboxyl 
terminated 50:50 poly(lactic-co-glycolic) acid (PLGA) (LACTEL Absorbable Polymers) in 
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a nanoprecipitation process. The PLGA polymer was first dissolved in acetone at a 
concentration of 10 mg/mL. One milliliter of the solution was then added to 1 mL of 
UltraPure water. For fluorescently labeled formulations, 1,1’-Dioctadecyl-3,3,3′,3′-
Tetramethylindodicarbocyanine Perchlorate (DiD) (Life Technologies Corporation) was 
loaded into the polymeric cores at 0.1 wt%. The mixture was next stirred under vacuum for 
3 hours. RBC membrane coating was obtained by fusing RBC membrane vesicles with 
PLGA particles via sonication using an FS30D bath sonicator at a frequency of 42 kHz and 
a power of 100 W for 2 min. The size and the zeta-potential of the resulting RBCNS were 
obtained from three dynamic light scattering measurements using a Malvern ZEN 3600 
Zetasizer, which showed an average hydrodynamic diameter of 100 nm and 115 nm before 
and after the membrane coating process, respectively.
To determine binding of RBCNS to GAS cells, 2 mL of the indicated strain overnight 
culture was mixed in 1:1 ratio with mixture of 1 part VECTASHIELD Mounting Medium 
with DAPI (Fisher Scientific) and 9 parts 10% sucrose or with 10% sucrose, 4% bovine 
serum albumin (BSA) (VWR International, LLC) and incubated for 30 minutes at room 
temperature. Solutions were next centrifuged for 8 minutes at 3,000 × g, room temperature 
and washed twice with 10% sucrose. Pelleted bacteria were suspended in 10% sucrose 
(original culture volume), placed on ice and incubated for 5 min with or without RBCNS. 
Afterward, 1 mL of 10% sucrose was added and samples were centrifuged for 8 minutes at 
3,000 × g, room temperature, washed three times, and suspended in 10% sucrose. A TECAN 
plate reader was used to measure fluoresce intensity of DiD at excitation/emission 630/670 
nm and DAPI at excitation/emission 358/461 nm. Measurements of DAPI-free and RBCNS-
free bacteria were used to determine the fluorescent background. The RBCNS binding by 
bacterial cells was calculated using formula (NS /DAPI –B), where NS = DiD fluorescence 
signal (excitation/emission 630/670 nm); DAPI = DAPI fluorescence signal (excitation/
emission 358/461 nm); B - fluorescence signal of DAPI- and RBCNS-free bacterial cells 
(excitation/emission 358/461 nm). Experiments were performed in biological triplicate.
α-S Protein Bacterial Blocking—Bacteria were cultured overnight and diluted to 107 
CFU/mL concentration. Bacteria were subjected to centrifugation at 10,000 × g for 10 
minutes at room temperature. Bacteria were resuspended in 1 mL 1× sterile PBS and 
subjected to centrifugation at 10,000 × g for 10 minutes at room temperature. The wash step 
was repeated once more. Washed bacteria were suspended in 1 mL of RPMI 1640 medium 
supplemented with 10% heat inactivated normal human serum, incubated for 20 minutes 
shaking at room temperature, washed with PBS as above, and suspended in 1 mL of RPMI 
1640. Serum collected from rabbits on the pre-immunization bleed day and the final post-S 
protein immunization day were incubated at 56°C for 20 minutes and added to bacterial 
suspensions at 1:100 dilutions. Bacteria were incubated shaking for 40 minutes at room 
temperature. Bacteria were pelleted at 10,000 × g for 10 minutes, supernatants removed, and 
pellets were resuspended in 200 μL of THY broth. For RBC binding studies, 100 μL of each 
bacterial suspension was incubated with 100 μL of RBCs prepared as described above. 
Mixtures were incubated at 37°C for 1 hour, then pelleted at 10,000 × g for 10 minutes at 
room temperature. Complete RBC lysis was ensured by measuring heme release as 
described above. Bacteria were resuspended in 800 μL of sterile 0.75× PBS. Bacteria were 
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pelleted, imaged, and resuspended prior to serial titration and plating on THY+2 μg/mL 
erythromycin plates for enumeration.
Measurement of Δess pDCerm::emm1 Cell Sedimentation—The effect of elevated 
M protein expression in the Δess genetic background on cell aggregation and sedimentation 
was analyzed as follows. Bacterial strains were inoculated in the morning in 10 mL of liquid 
medium, incubated at 37°C for 8 hours, back-diluted (1:20) in 10 mL of fresh medium (in a 
15 mL falcon tube), and incubated for 18 hours at 37°C. On the following day, tubes were 
spun down (1 minute, 500 × g, room temperature) to bring down all aggregated cells to the 
bottom of the tube. Sedimented cell pellet heights and top diameters were measured with a 
millimeter scale ruler and non-sediment culture OD600 values were determined. Cultures 
were next vortexed, serially diluted (10−1 − 10−5) in PBS. 5 μL of each sample was spotted 
on solid medium for CFU/mL scoring in technical duplicate. Sedimented bacterial volume 
(mm3) was calculated using the volume equation for a circular truncated cone:
(1/3)π r1
2 + r1r2 + r2
2 h; where r1 = radius of the top of the sedimented cells; r2 = radius of the 
bottom of the sediment cells (constant value of 2 mm); h = height of the sedimented cells. 
Experiments were performed in three biological replicates.
Mouse Systemic Infection Model—To determine the fitness of GAS strains during 
mouse systemic infection, overnight cultures of indicated bacterial strains were back-diluted 
(1:20) in 10 mL of fresh medium and incubated at 37°C for 4 hours to mid-exponential 
phase of growth. Cultures were next harvested (10 minutes centrifugation at 10,000 × g, 
room temperature) and pelleted bacteria were suspended in PBS to cell density of 108 
CFU/mL. Bacteria were serially diluted (10−1 − 10−6) in PBS and 5 μL spotted (in technical 
duplicates) on solid medium for exact CFU enumeration. The 6–8 week old female CR 
(CD-1) mice (10 per group) were infected with 100 μL of bacterial suspensions (107 CFU) 
via lateral tail vein injection. Control animals were injected with PBS alone. Animal survival 
and weight (g) was monitored daily for 10 days. Change in body weight was calculated with 
the following formula: (W× /W0)×100, where W0 = animal weight at the day of the 
infection and W× = animal weight at indicated day.
To determine whether RBC membrane-binding molecular mimicry affected GAS virulence 
during mouse systemic infection, overnight cultures of wt pDCerm strains was back-diluted 
(1:20) in 10 mL of fresh medium, incubated at 37°C for 4 hours, mixed with equal volumes 
of PBS or 4% mouse RBC solution (prepared as described in the Quantitative in vitro 
hemolytic activity assay section), and incubated for 1 hour at 37°C. The subsequent steps 
were performed as described above.
For analysis of bacterial load in the blood and organs of infected animals, bacterial 
suspensions were prepared and administered to animals (7 per group) as described above. At 
day 4 post-infection, blood was collected, animals were sacrificed and perfused with PBS 
(administered through the apex of the left ventricle of the heart). Organs (liver, kidneys, 
spleen, lungs, and heart) were next removed, submerged in 1 mL of PBS, and homogenized 
for 1 minute in Mini-Beadbeater-24 (BioSpec Products) with Ceramic Beads (BioSpec 
Products). Blood and homogenized organs were next serially diluted in (10−1 − 10−6) in PBS 
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and 10 μL of undiluted or 5 μL diluted blood/tissue was spotted on solid medium (with or 
without supplementation of erythromycin) for bacteria enumeration. Maintenance of the 
pDCerm vectors among bacterial strains during infection (named here “Plasmid 
maintenance”) was calculated by formula: (CFU S /CFU NS), where CFU S = CFU/mL of 
bacteria that grew on a selective medium (with erythromycin), CFU NS = CFU/mL of 
bacteria that grew on a non-selective medium (without erythromycin). In situation where no 
bacteria were recovered on one of the media types, a 10-fold lower CFU/mL value of the 
other media type was assigned to it.
For analysis of bacterial load in the blood and spleens through the initial 4 days of infection 
and spleen collection for proteomic analysis, bacterial suspensions were prepared and 
administered to animals (5 per group for each day of the study) as described above. Control 
animals were mock-infected with PBS. During the subsequent 4 days post-infection, weight 
measurements of animals were taken before blood collection and spleen harvesting 
(performed as described above). Prior to tissue homogenization, spleen weight 
measurements were taken. Following plating (on solid media without erythromycin) for the 
bacterial CFU/mL determination, homogenized spleens were immediately transferred to 
−80°C. Spleen weight as a percent of the total body mass was calculated with following 
formula: (SW /BW)×100, where SW = spleen weight and BW = weight of the entire animal.
For studies involving Ifnar1 −/− mice, mice were infected with 107 CFU of Δess GAS or 
administered PBS via lateral tail vein injection (n = 8 per group). Survival was monitored for 
3 weeks following injection.
Protection Studies with Δess Strain—In order to test if mice exposed to systemic 
infection with Δess developed adaptive immunity against the wt pDCerm strain, overnight 
cultures of the mutant strain were back-diluted (1:20) in 10 mL of fresh medium and 
incubated at 37°C to mid-exponential phase of growth (4 hours of growth). Cultures were 
centrifuged for 10 minutes at 10,000 × g at room temperature, and cells were suspended in 
PBS to a concentration of 3 × 108 CFU/mL. Bacteria were serially diluted (10−1 − 10−6) in 
PBS and 5 μL spotted on solid medium for exact CFU determination in technical duplicate. 
A group of 20 CR (CD-1) mice (6–8 week old) were administered 100 μL of a bacterial 
suspension containing approximately 3 × 107 CFU through lateral tail vein injection. 20 
control animals were injected with PBS. After 3 weeks, half of the mice from each group 
were infected with 5 × 107 CFUs of wt pDCerm (bacteria suspension was prepared as 
described above), and the second half of each group was mock-infected with PBS. Animal 
survival and weight (g) were monitored daily for 10 days. Changes in body weight were 
calculated as described in the above section. At the end of day 10 post-infection, blood from 
surviving animals was collected into heparin-coated Eppendorf tube for serum isolation.
SDS-PAGE and Western Blotting—Bacterial samples from liquid cultures were 
obtained by separating cells from culture supernatants by 10 minutes centrifugation at 
10,000 × g at room temperature. Samples were normalized based on the total protein 
concentration or optical density (OD600) of bacterial culture and boiled for 10 minutes in 4× 
Laemmli Sample Buffer (Bio-Rad Laboratories) containing 50 mM Dithiothreitol (DTT) 
(Invitrogen). Samples were separated on either 10% or 15% polyacrylamide gels. Following 
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electrophoresis, proteins were stained with InstantBlue (Expedeon) or transferred onto 0.2 
μm nitrocellulose membrane (Bio-Rad Laboratories) using a Trans-blot Turbo (Bio-Rad 
Laboratories) system. Membranes were incubated in 5% milk suspension in PBS with 0.1% 
Tween 20 (VWR International, LLC) (PBST) for 1 hour, briefly washed with PBST, 
incubated for 1 hour in primary antibodies diluted in a 5% milk suspension in PBST, washed 
3 times (10 minutes each) with PBST, incubated with secondary HRP conjugate antibodies 
for 1 hour, and finally washed 3 times (8 minutes each) with PBST. Immunoblots were 
incubated for 5 minutes in SignalFire ECL Reagent (Cell Signaling Technology, Inc.) mix 
and visualized with Chemi-DocTM MP System (Bio-Rad Laboratories). Primary antibodies 
were used at indicated dilutions: rabbit polyclonal anti-S protein 1:5000, mouse polyclonal 
anti-M protein 1:1000, pooled mouse serum from experimental groups 1:5000. Secondary 
antibodies, Goat Anti-Rabbit IgG H&L (HRP) and Goat F(ab) Anti-Mouse IgG H&L (HRP) 
(Abcam, Inc.), were used at 1:10,000 dilution.
Proteomics Analyses—Samples of whole cells and culture supernatants of wild-type, 
Δess, and complemented GAS M1 5448 were collected by centrifugation of overnight 
cultures (10 mL) for 10 minutes at 10,000 × g at 4°C. A quarter of cOmplete, Mini, EDTA-
free Protease Inhibitor Cocktail tablet was added immediately to each filter sterilized (0.22 
μm) culture supernatant and samples were stored −80°C until used. Bacterial cells and 
culture supernatants were collected on three separate occasions.
Sample lysis was performed as follows. Bacterial cell pellets were suspended in 500 μL of 
lysis buffer composed of 75 mM NaCl, 3% sodium dodecyl sulfate (SDS) (Fisher 
Scientific), 1 mM sodium Fluoride (VWR International, LLC), 1 mM beta-glycerophosphate 
(Sigma Aldrich), 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate (VWR 
International, LLC), 1 mM phenylmethylsulfonyl fluoride (Fisher Scientific), 50 mM 
HEPES (Fisher Scientific) pH 8.5, and 1X cOmplete EDTA-free protease inhibitor cocktail, 
plus 500 μL of 8M Urea (Fisher Scientific), 50 mM HEPES pH 8.5, and subjected to 
sonication using a Q500 QSonica sonicator (Qsonica) equipped with 1.6 mm microtip at 
amplitude 20%. Samples were subjected to 10 s of sonication followed by 10 s of rest, with 
a total sonication time of 30 s. For mouse spleens, 500 μL of lysis buffer and 500 μL of 8M 
Urea, 50 mM HEPES pH 8.5 was added to homogenized samples in PBS. In order lyse any 
remaining intact tissue, spleens were subjected to an additional three rounds of 1 minute 
bead beating in a Mini-Beadbeater-24 at 4°C with 1 minute of rest between cycles. For 
immunoprecipitated antigens, the lysis step was omitted, and only 210 μL of 8M Urea, 50 
mM HEPES pH 8.5 was added.
Protein extraction and digestion was performed as follows. Reduction of disulfide bonds was 
performed by addition of DTT to a final concentration of 5 mM. Samples were incubated for 
30 minutes at 56°C. Iodoacetamide (IAA) (Sigma Aldrich) was added to a final 
concentration of 15 mM and samples were incubated in a darkened environment for 20 
minutes at room temperature. The reaction was quenched by adding 5mM DTT and 
incubated in a darkened environment for 15 minutes at room temperature. Proteins from 
spleen samples and bacterial culture supernatants were precipitated using chloroform-
methanol precipitation (Wessel and Flügge, 1984). Briefly, protein solutions were mixed 
with 6 mL of methanol, 1.5 mL of chloroform, and 4 mL of HPLC-grade water. Samples 
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were briefly vortexed and centrifuged for 2 minutes at 4,000 rpm at room temperature. The 
resulting supernatants were aspirated and an additional 6 mL of methanol was added to the 
pellets. Samples were briefly vortexed and centrifuged for 2 minutes at 4,000 rpm. 
Supernatants were again aspirated. Protein pellets were placed on ice and washed three times 
with 3 mL of ice cold acetone (Fisher Scientific) (briefly vortexing and 2 minutes spin at 
4,000 rpm at 4°C). Proteins from bacterial cell pellets and immunoprecipitated antigens 
were precipitated by adding 1/4 of the total volume of trichloroacetic acid (TCA) (Fisher 
Scientific) to the samples, briefly vortexing the samples, and incubating samples on ice for 
10 minutes. Samples were spun down for 5 minutes at 16,000 × g at 4°C. Protein pellets 
were washed three times with 300 μL of ice cold acetone. The chloroform-methanol- and 
TCA-precipitated proteins were dried at 56°C.
Protein Digestion and Tandem Mass Tag (TMT)-Labeling was performed as follows. Dried 
bacterial protein pellets (from whole cells, culture supernatants, and immunoprecipitated 
antigens) were suspended in 300 μL of digestion buffer comprised of 1M urea and 50mM 
HEPES pH 8.5, while dried mouse spleen proteins were suspended in 900 μL of the same 
buffer. Samples were vortexed for 5 minutes and sonicated in a water bath for 5 minutes. 
Bacterial and mouse proteins were digested by adding 3 or 9 μg of LysC Endopeptidase 
(VWR International, LLC), respectively, and shaking overnight at room temperature. 
Following day, 3 or 8.6 μg of Sequencing Grade Modified Trypsin (Core Bio Services) was 
added to bacterial or mouse proteins, respectively, and samples were incubated for 6 hours at 
37°C. The digestion reactions of bacterial, mouse, and immunoprecipitation samples was 
terminated by acidifying the solution with 20 μL, 60 μL of 10% trifluoroacetic acid (Sigma 
Aldrich), or 20 μL of 10% trifluoroacetic acid plus 300 μL 0.1% of trifluoroacetic acid, 
respectively. Insoluble debris was separated by centrifuging the samples for 5 minutes at 
16,000 × g at room temperature. Supernatants containing digested soluble peptides of 
bacterial whole cell lysates and culture supernatants, and mouse splenic tissues were 
desalted using C18 resin columns (Sepax). Peptides from immunoprecipitated antigens were 
desalted using a STAGE (STop And Go Extraction) TIPS Desalting Procedure, and dried 
under vacuum. All samples, with the exception of the immunoprecipitated antigens, were 
next suspended in a solution of 50% acetonitrile (VWR International, LLC) and 5% formic 
acid (Fisher Scientific) and peptide content was quantified with Pierce Quantitative 
Colorimetric Peptide Assay (Fisher Scientific). 50 μg of peptides from each sample was 
separated for further analysis, with the exception of the bacterial supernatants samples, 
which displayed chronically low yields. Therefore, 37 μg from bacterial supernatant samples 
were separated for further study. Internal standard bridge channels were prepared for mouse 
splenic tissues and bacterial whole cell samples using methods previously described (Lapek 
et al., 2017b). Briefly, 5.83 μg of each sample was mixed together and separated into seven 
50 μg aliquots. Internal standards were dried under vacuum. The immunoprecipitated 
antigens were suspended in 50 μL of 30% dry acetonitrile with 200 mM HEPES pH 8.5 and 
the entire sample was used for TMT-labeling. TMT reagents were prepared by vortexing for 
5 minutes in a solution of 30% dry acetonitrile with 200 mM HEPES pH 8.5 to a final 
concentration of 20 μg/μL. Label assignment was performed such that no sample replicates 
were assigned to the same label. Bridge channels were assigned to channel 126 for spleen 
and whole cell bacteria experiments. Protein aliquots were incubated with 8 μL of suspended 
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TMT labels for 1 hour at room temperature. Reaction quenching was performed by adding 9 
μL of 5% hydroxylamine (Sigma Aldrich) to the labeling reaction and incubating for 15 
minutes at room temperature. Following the reaction quenching, samples were acidified with 
50 μL of 1% trifluoroacetic acid. Following labeling, samples within each 10-plex were 
pooled, and with exception to immunoprecipitated antigens, desalted, and lyophilized 
(McAlister et al., 2014; Thompson et al., 2003; Wang et al., 2011).
Reverse-Phase High pH Liquid Chromatography Sample Fractionation of bacterial and mice 
TMT-labeled samples was performed as follows. Lyophilized multiplexed samples were 
suspended in a solution of 5% acetonitrile, 5% formic acid and fractionated using reverse-
phase high pH liquid chromatography on an Ultimate 3000 HPLC with 4.6 mm × 250 mm 
C18 column. Samples were separated on a gradient progressing from 5% to 90% acetonitrile 
in 10 mM ammonium bicarbonate (Fisher Scientific) for one hour. For labeled and pooled 
immunoprecipitated antigens, Pierce High pH Reversed-Phase Peptide Fractionation Kit 
(Fisher Scientific) was used for sample fractionation. Of the 96 and 8 fractions produced for 
bacteria/mice and immunoprecipitated antigens samples, respectively; concatenated 
fractions were pooled as previously described (Wang et al., 2011). Alternating pooled sets 
were lyophilized under vacuum.
LC-MS/MS was performed as follows. Dried fractions were suspended in 8 μL of 5% 
acetonitrile and 5% formic acid solution, vortexed for 5 minutes, and sonicated in a water 
bath for 5 minutes. Experiments were performed on an Orbitrap Fusion mass spectrometer 
with in-line Easy-nLC. Fractions were run on three-hour gradients beginning with elution 
solution containing 3% acetonitrile and 0.125% formic acid and ending with an elution 
solution containing 100% acetonitrile and 0.125% formic acid. Peptides were separated 
using an in house-packed 30 cm × 100 μm inner diameter, 360 μm outer diameter column 
comprised of 0.5 cm C4 resin (diameter = 5 μm), 0.5 cm C18 resin (diameter = 3 μm), and 
29 cm C18 resin (diameter = 1.8 μm). Source ionization was performed by applying 2000V 
of electricity through the T-junction joining sample, waste, and column capillary termini.
MS1 spectrum acquisition was performed in data-dependent mode with Orbitrap survey scan 
range of 500 – 1200 m/z and resolution of 60,000. Automatic gain control (AGC) 2 × 105 
with maximum ion inject time of 100 ms. Top N was used with N = 10 for both MS2 and 
MS3 fragment ion analysis.
MS2 data were collected using the decision tree option. Ions carrying 2 charges were 
analyzed between 600 – 1200 m/z, and ions carrying 3 or 4 charges were analyzed between 
500 – 1200 m/z. The ion intensity threshold was 5 × 104. Selected ions were isolated in the 
quadrupole at 0.5 Th and fragmented via Collision Induced Dissociation (CID). Fragment 
ion detection and data centroiding occurred in the linear ion trap with rapid scan rate AGC 
target of 1 × 104.
TMT-based quantitation via MS3 fragmentation was performed using synchronous precursor 
selection. Up to 10 MS2 precursors were concurrently fragmented using High Energy 
Collisional Dissociation (HCD) fragmentation. Reporter ions were detected in the Orbitrap 
at a resolution of 60,000 and with a lower threshold of 110 m/z. AGC was set to 1 × 105 with 
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maximum ion inject time of 100 ms. Data collected was centroided and precursor ions 
outside of 40 m/z below and 15 m/z above the MS2 m/z were removed.
Data Processing and Normalization was performed as follows. Raw spectral data were 
processed using Proteome Discoverer 2.1. Spectral matching at the MS2 level was 
performed against the UniProt Streptococcus pyogenes serotype M1 reference proteome 
downloaded on 1/29/2018 or Mus musculus reference proteome downloaded on 11/28/2016. 
The Sequest algorithm was used for spectral matching and in silico decoy database 
construction (Eng et al., 1994). Precursor ion mass tolerance was set to 50 ppm and 
fragment ion mass tolerance was set to 0.6 Da. The digesting enzyme was specified as 
trypsin, with two missed cleavages allowed and peptide length range between 6 – 144 amino 
acids. Methionine oxidation was used as dynamic modification (+15.995 Da). Used static 
modifications included isobaric tandem mass tags at peptide N-termini and on lysine 
residues (+229.163 Da) and carbamidomethylation of cysteine residues (+57.021 Da). A 
false discovery rate of 1% was used for filtering at both the peptide and protein levels in 
Percolator using the aforementioned decoy database (Käll et al., 2007; Spivak et al., 2009).
The single pooled bridge channel assigned to TMT-126 was used for normalization of values 
across 10-plexes for the spleen tissues and whole cell lysate bacterial proteomics 
experiments, while the supernatants proteomics data were normalized against average values 
for each protein. Bridge channels had been eschewed for the bacterial supernatants 
proteomics experiment due to a low protein yield following precipitation. Briefly, data were 
filtered for high peptide spectral match (PSM) confidence and PSM unambiguity/selection. 
Quantification values were normalized against protein bridge channel values or protein 
average value and subsequently to the median value of all bridge channels or averages. The 
resulting quantification values were next adjusted for variation in labeling efficiency by 
normalizing against the median values for each TMT label and the median of the channel 
medians. To adjust the data for an observed 10-plex-based batch effect, the frozen surrogate 
variable analysis (fSVA) R package was used (Parker et al., 2014).
QUANTIFICATION AND STATISTICAL ANALYSIS
All data, excepting proteomics datasets, were analyzed and plotted using GraphPad Prism 7. 
Mean values with corresponding ± SEM are presented; Kaplan-Meier survival curves were 
prepared for Figures 4A, S3A, and 6A. GraphPad Prism’s built-in Student’s t test and one 
way ANOVA were used to determine statistical significance (p < 0.05).
For bacterial whole cells and culture supernatants proteomic data statistical significance (p < 
0.05) was determined by using Microsoft Excel’s built-in Student’s t test with Welch’s 
Correction where appropriate based on an antecedent F test. Further stringency was imposed 
on binary comparisons through the use of the pi score calculation, which accounts for both 
statistical significance and fold change (Xiao et al., 2014). A pi score cutoff of 1.1082 was 
used to identify differentially expressed proteins between the various GAS strains profiled. 
Annotation of significantly altered proteins was performed manually. Treemaps were 
generated using the treemap R package.
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For mouse spleen proteomic data, unbiased clustering was performed using the amap R 
package. Distance measurement was performed using the Spearman method and the average 
agglomeration method was used for clustering. Dendrogram generation was performed using 
the ape R package. Heatmap generation was performed using the gplots R package. STEM 
clustering was performed using the Short Time series Expression Miner (STEM) software 
package (Ernst and Bar-Joseph, 2006). Eight clusters were generated using the average 
values for each treatment group time series. For protein interaction network analysis, protein 
lists generated using STEM clustering were subjected to analysis using String-db (https://
string-db.org/cgi/input.pl). Interactions were filtered for aggregate scores greater than 0.7 
(high confidence). Network figures were generated using Cytoscape v3.7.1. Fold difference 
was calculated by dividing wild-type and Δess abundance values by the average of the PBS 
values, then calculating Log2 of the wild-type versus Δess values. P values were calculated 
using the PBS-normalized values.
DATA AND CODE AVAILABILITY
The mass spectrometry proteomics data have been deposited into MassIVE (https://
massive.ucsd.edu/ProteoSAFe/static/massive.jsp) and submitted to the ProteomeXchange 
Consortium (http://proteomecentral.proteomexchange.org) with the dataset identifiers 
PXD015341 for bacterial proteomics, PXD015342 for supernatant proteomics, and 
PXD015343 for spleen proteomics.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• S protein promotes red blood cell binding to group A Streptococcus (GAS) 
cell surface
• Red blood cell membrane binding is an immune evasion tactic used by GAS
• Lack of S protein results in a drastic reduction of virulence during systemic 
infection
• Attenuated virulence during Δess infection is associated with altered 
immunity
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Figure 1. S Protein Discovery and Initial Characterization
(A) Schematic of S protein discovery by Biomimetic Virulomics.
(B) Localization of ess (SPy_0802) and surrounding genes.
(C) Predicted protein architecture of S protein.
(D) α-S protein antiserum validation of cells (Cs) and supernatants (Ss).
(E) Western blotting analysis of S protein secretion and processing in Cs and Ss during 
growth of wild-type (WT) GAS.
(F) Photographic documentation of GAS sedimentation after overnight growth.
(G) Proliferation of GAS strains in standard growth medium (G, bacterial generation time), 
in biological triplicate with data as mean ± SEM (*p < 0.05).
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(H) Proliferation of GAS strains in standard growth medium, in biological triplicate with 
data as mean ± SEM (*p < 0.05).
(I) Photographic documentation of culture sedimentation during exponential phase.
(J) Sedimentation of GAS overnight cultures mixed with water measured as a change in 
optical density 600 (OD600) over 5 h, in biological triplicate with data as mean ± SEM (*p < 
0.05).
(K) Sedimentation of GAS overnight cultures mixed with methanol measured as a change in 
OD600 over 5 h, in biological triplicate with data as mean ± SEM (*p < 0.05).
(L) Measurement of bacterial cells hydrophobic properties, in biological triplicate with data 
as mean ± SEM (*p < 0.05).
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Figure 2. S Protein Is Crucial for Survival in Human Blood and Coating of GAS Cells with Lysed 
RBC Fragments
(A) Proliferation of GAS strains in whole human blood, in biological triplicate with data as 
mean ± SEM (*p < 0.05).
(B) Photographic documentation of hemolytic properties of GAS strains on 5% sheep blood 
agar.
(C) Quantification of red blood cells lysis by GAS strains, in biological triplicate with data 
as mean ± SEM (*p < 0.05).
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(D) Bacterial survival in normal human serum (NHS), in biological triplicate with data as 
mean ± SEM (*p < 0.05).
(E) Quantification of GAS cells captured by THP-1-derived macrophages, in biological 
triplicate with data as mean ± SEM (*p < 0.05).
(F) Quantification of GAS cells phagocytosed by THP-1-derived macrophages, in biological 
triplicate with data as mean ± SEM (*p < 0.05).
(G) Quantification of bacterial survival within THP-1-derived macrophages, in biological 
triplicate with data as mean ± SEM (*p < 0.05).
(H) Quantification of recovered extracellular bacteria following incubation with neutrophils, 
in biological triplicate with data as mean ± SEM (*p < 0.05).
(I) Quantification of bacterial cells phagocytosed by neutrophils, in biological triplicate with 
data as mean ± SEM (*p < 0.05).
(J) Quantification of bacterial hyaluronic acid capsule, in biological triplicate with data as 
mean ± SEM (*p < 0.05).
(K) Quantification of RBCNS binding by Δess, in biological triplicate with data as mean ± 
SEM (*p < 0.05).
(L) Photographic documentation of pelleted GAS cell color after incubation in PBS or 2% 
RBC solution.
(M) Effect of RBC membrane binding on interaction with THP-1 derived macrophages, in 
biological triplicate with data as mean ± SEM (*p < 0.05).
(N) Effect of RBC membrane binding on proliferation of GAS strains in whole human 
blood, in biological triplicate with data as mean ± SEM (*p < 0.05).
(O) Survival of mice (n = 10) infected with WT GAS preincubated in PBS or 2% mouse 
RBC solution.
(P) Change in body weight of mice (n = 10) infected with WT GAS preincubated in PBS or 
2% mouse RBC solution.
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Figure 3. Absence of S Protein Reshapes Cellular and Extracellular Proteome Landscape
(A) Outline of proteomic workflow for GAS cells and supernatants collected as biological 
triplicates.
(B) Binary comparisons of protein abundance among analyzed bacterial strain cells. Proteins 
with π > 1.1082 are highlighted in cyan and yellow.
(C) Binary comparisons of protein abundance among analyzed bacterial strain supernatants. 
Proteins with π > 1.1082 are highlighted in pink and green. (D) Core set of GAS whole-cell 
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lysate proteome components affected by S protein. Orange and blue treemaps represent 
distribution of up- and downregulated proteins, respectively, among functional groups.
(E) Core set of GAS culture supernatant proteome components affected by S protein. Orange 
and blue treemaps represent distribution of up- and downregulated proteins, respectively, 
among functional groups.
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Figure 4. Δess Shows Attenuated Virulence in a Mouse Model of Systemic Infection
(A) Survival of mice (n = 10) infected with GAS WT and Δess strains.
(B) Change in body weight of mice (n = 10) infected with GAS WT and Δess strains, as 
mean ± SEM.
(C) Bacterial loads in mouse blood and organs on day 4 of systemic infection (n = 7), as 
mean ± SEM (*p < 0.05).
(D) Progression of bacterial burden in the blood during 4 initial days post-infection (n = 5), 
as mean ± SEM.
(E) Progression of bacterial burden in splenic tissues over 4 days post-infection (n = 5), as 
mean ± SEM.
(F) Changes in the size of spleens during infection (n = 5), as mean ± SEM.
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Figure 5. Lack of S Protein Leads to Elevated Interferon-Related Signaling during Early 
Infection and Adaptive Immunity Development
(A) Outline of the quantitative proteomic workflow for splenic tissues harvested from PBS 
mock-infected and GAS-infected mice on days 1–4 (n = 5).
(B) Circular dendrogram of Spearman clustering for all samples. Treatment and time point 
are represented in the inner and outer circle, respectively.
(C) Protein interaction network of Δess-infected spleen cluster 7 using day 4 abundance 
values.
(D) Protein interaction network of Δess infected spleen cluster 0 and 1 using day 1 
abundance values.
(E) Survival of Ifnar1−/− mice following Δess infection (n = 8).
(F) Survival of PBS- or Δess-inoculated mice during re-infection with WT GAS (groups: 
PBS → PBS, n = 10; PBS → WT, n = 10; Δess → PBS, n = 8; Δess → WT, n = 8).
(G) Change in body weight of PBS- or Δess-inoculated mice during re-infection with WT 
GAS (groups: PBS → PBS, n = 10; PBS → WT, n = 10; Δess → PBS, n = 8; Δess → WT, 
n = 8). Data are represented as mean ± SEM.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit polyclonal Anti-S protein This work N/A
Mouse polyclonal Anti-M1 protein Kindly provided by Dr. Victor 
Nizet (UCSD) (Hollands et al., 
2010)
N/A
Mouse antibodies against various S. pyogenes M1 5448 protein 
(pooled serum obtained from 4 animal experimental groups)
This work N/A
Goat Anti-Rabbit IgG H&L (HRP) Abcam, Inc. Cat#ab6721; RRID: AB_955447
Goat F(ab) Anti-Mouse IgG H&L (HRP) Abcam, Inc. Cat#ab6823; RRID: AB_955395
Bacterial and Virus Strains
Escherichia coli NEB 5-alpha New England BioLabs Cat#C2987I
Escherichia coli NEB Turbo New England BioLabs Cat#C2984I
Escherichia coli NEB Turbo pHY304 This work N/A
Escherichia coli NEB Turbo pHY304-ess::cat This work N/A
Escherichia coli NEB 5-alpha pDCerm This work N/A
Escherichia coli NEB 5-alpha pDCerm::ess This work N/A
Escherichia coli NEB Turbo pDCerm::emm1 This work N/A
Escherichia coli BL21(DE3) New England BioLabs Cat# C2527I
Escherichia coli BL21(DE3) N-HisPP-pET-28a(+)::ess This work N/A
Streptococcus pyogenes M1 5448 Private laboratory stock; 
originally provided by Dr. Victor 
Nizet (UCSD) (Chatellier et al., 
2000)
N/A
Streptococcus pyogenes M1 5448 pHY304-ess::cat This work N/A
Streptococcus pyogenes M1 5448 Δess This work N/A
Streptococcus pyogenes M1 5448 pDCerm This work N/A
Streptococcus pyogenes M1 5448 Δess pDCerm This work N/A
Streptococcus pyogenes M1 5448 Δess pDCerm::ess This work N/A
Streptococcus pyogenes M1 5448 Δess pDCerm::emm1 This work N/A
Chemicals, Peptides, and Recombinant Proteins
Todd Hewitt Broth Spectrum Laboratory Products, 
Inc.
Cat#743–29433-12
Yeast Extract VWR International, LLC Cat#90000–026 (EA)
Agar Granulated VWR International, LLC Cat#90000–782 (EA)
Mueller Hinton Agar w/5% Sheep Blood Fisher Scientific Cat#R04055
Erythromycin Spectrum Laboratory Products, 
Inc.
Cat# TCI-E0751–25G
Difco LB Agar, Miller (Luria-Bertani) Spectrum Laboratory Products, 
Inc.
Cat#743–29229-10
LB Agar Core Bio Services Cat#C121
Kanamycin sulfate BioPioneer Cat#C0031
Glycerol VWR International, LLC Cat#IC19520491 (EA)
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REAGENT or RESOURCE SOURCE IDENTIFIER
RPMI 1640 Medium (ATCC modification) Life Technologies Corporation Cat#A1049101
Fetal Bovine Serum (USDA Certified, Heat Inactivated) Core Bio Services Cat#FB-02
GIBCO 2-Mercaptoethanol Life Technologies Corporation Cat#21985023
Phorbol 12-myristate 13-acetate Sigma Aldrich Cat#P8139–10MG
Q5® High-Fidelity DNA Polymerase New England BioLabs Cat# M0491L
Deoxynucleotide (dNTP) Solution Mix New England BioLabs Cat#N0447S
EagI-HF New England BioLabs Cat#R3505S
HindIII-HF New England BioLabs Cat#R3104S
SOC Outgrowth Medium New England BioLabs Cat#B9020S
Quick-Load® Taq 2X Master Mix New England BioLabs Cat#M0271L
Glycine Anhydride Spectrum Laboratory Products, 
Inc.
Cat#G3063–100GM
Sucrose Sigma Aldrich Cat# RDD023–1KG
Magnesium Chloride Hexahydrate, MgCl2 ⋅ 6H2O Fisher Scientific Cat#ICN19469880
Phosphate Buffered Saline (PBS-20X) Cell Signaling Technology Cat#9808S
KpnI-HF New England BioLabs Cat#R3142S
BamHI-HF New England BioLabs Cat#R3136T
Isopropyl β-D-1-thiogalactopyranoside (IPTG) Omega Scientific Cat#IP-05
Tris(Base) Avantor Performance Materials Cat#JT4109–2
Imidazole Sigma Aldrich Cat#792527–500G
L-Arginine, 98+% VWR International, LLC Cat# AAA15738–14
L-Glutamic Acid Spectrum Laboratory Products, 
Inc.
Cat#G1036–1KG
Triton X-100 Polyethylene Glycol p-tert-Octylphenyl Ether Fisher Scientific Cat#BP151100
Lysozyme BioPioneer Cat#C0021
Ni-NTA Agarose QIAGEN Cat#30210
Precision Plus Protein Unstained Standards Bio-Rad Laboratories Cat#1610363
InstantBlue Core Bio Services Cat# ISB1L
FM4–64 Dye (N -(3-Triethylammoniumpropyl)-4-(6-(4-
(Diethylamino) Phenyl) Hexatrienyl) Pyridinium Dibromide)
Life Technologies Corporation Cat#T3166
DAPI Sigma Aldrich Cat#D9542–10MG
SYTOX Green Nucleic Acid Stain - 5 mM Solution in DMSO Life Technologies Corporation Cat#S7020
Agarose (Broad Separation Range for DNA/RNA/Genetic Analysis 
Grade)
Fisher Scientific Cat#BP1356500
Ammonium sulfate, Enzyme grade, ≥ 99%, (NH4)2SO4 Fisher Scientific Cat#ICN15037380
Potassium Phosphate Dibasic Trihydrate ≥ 99%, K2HPO4 ⋅ 3H2O Fisher Scientific Cat#ICN19484580
Potassium Phosphate Monobasic, 99+%, KH2PO4 Fisher Scientific Cat#ICN19472790
Sodium citrate dehydrate, 99%, Trisodium citrate dihydrate, 
C6H5O7Na3 ⋅ 2H2O
Fisher Scientific Cat#ICN19486894
Methanol, ≥ 99.9%, Methyl Alcohol, CH4O Fisher Scientific Cat#A4524
Urea Fisher Scientific Cat#U15500 (CS)
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REAGENT or RESOURCE SOURCE IDENTIFIER
Magnesium sulfate heptahydrate, MgSO4 ⋅ 7H2O Sigma Aldrich Cat#M2773–500G
n-Hexadecane, CH3(CH2)14CH3 Fisher Scientific Cat#AAA10322AE
Triton® X-100 VWR International, LLC Cat#IC807423 (EA)
Carboxyl terminated 50:50 poly(lactic-co-glycolic) acid (PLGA) LACTEL Absorbable Polymers Cat#B6013–2
DiD’ oil; DiIĈ18^(5) oil (1,1’-Dioctadecyl-3,3,3′, 3′-
Tetramethylindodicarbocyanine Perchlorate)
Life Technologies Corporation Cat#D307
VECTASHIELD Mounting Medium with DAPI Fisher Scientific Cat# NC9524612
Bovine Serum Albumin (BSA) VWR International, LLC Cat#IC810032 (EA)
Normal Human Serum Fisher Scientific Cat#5058826
Gentamicin, 10 mg/mL VWR International, LLC Cat#10128–220 (EA)
Hyaluronic acid sodium salt from Streptococcus equi Sigma Aldrich Cat#53747–1G
Stains-all, 97%, 1-Ethyl-2-[3-(1-ethylnaphtho [1, 2-d]thiazolin-2-
ylidene)-2-methylpropenyl] naphtho[1, 2-d]thiazolium bromide, 
C30H27BrN2S2
Fisher Scientific Cat#AC213510010
Acetic Acid, Glacial, CH3COOH Fisher Scientific Cat#MKV155500
Formamide VWR International, LLC Cat#PI17899 (EA)
Chloroform Fisher Scientific Cat#C6061
EDTA 0.5M PH8.0 Fisher Scientific Cat#50983251
Protein A/G Agarose Max Flow, Highly Cross-linked Beads, 4% Genesee Scientific Corporation Cat#20–540
EGTA Fisher Scientific Cat#507516812
4× Laemmli Sample Buffer Bio-Rad Laboratories Cat#1610747
UltraPure Dithiothreitol (DTT) Invitrogen Cat#15508013
Tween 20 Detergent VWR International, LLC Cat#80503–492 (EA)
SignalFire(tm) ECL Reagent Cell Signaling Technology, Inc. Cat#6883S
cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail Tablets Roche Diagnostics Cat#11836170001
Sodium Chloride Sigma Aldrich Cat#S7653–250G
Sodium Dodecyl Sulfate (SDS) Fisher Scientific Cat#BP8200–500
Sodium Fluoride VWR International, LLC Cat#JT3688–1 (EA)
beta-Glycerophosphate disodium salt hydrate Sigma Aldrich Cat#G5422–500G
Sodium Vanadate Sodium Orthovanadate, Na3O4V Fisher Scientific Cat#S454–50
Sodium Pyrophosphate Decahydrate VWR International, LLC Cat#JT3850–1 (EA)
Phenylmethylsulfonyl Fluoride PMSF, C7H7FO2S Fisher Scientific Cat#71105GM
HEPES > = 99% N-(2-Hydroxyethyl)piperazine- N-2-ethanesulfonic 
Acid, C8H18N2O4S
Fisher Scientific Cat#BP310500
Iodoacetamide (IAA) Sigma Aldrich Cat#I1149–5G
Trichloroacetic Acid > = 99.0% TCA, C2HCl3O2 Fisher Scientific Cat#A322500
Acetone 99.5% min by GC 2-Propanone, C3H6O Fisher Scientific Cat#A949SK1
LysC Endopeptidase, Mass Spectrometry Grade, Wako VWR International, LLC Cat#100369–826 (EA)
V5113 Sequencing Grade Modified Trypsin Core Bio Services Cat#V5113
TMT10plex Isobaric Label Reagent Set Fisher Scientific Cat#PI90110
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REAGENT or RESOURCE SOURCE IDENTIFIER
Acetonitrile, Anhydrous Fisher Scientific Cat#NC9077861
Hydroxylamine solution Sigma Aldrich Cat#467804–50ML
Trifluoroacetic Acid Sigma Aldrich Cat#299537–100G
Acetonitrile for HPLC VWR International, LLC Cat#BJAH015–4PC (CS)
Formic Acid, 88% Methanoic Acid, CH2O2 Fisher Scientific Cat#A118P500
Ammonium bicarbonate Fisher Scientific Cat#09830–1KG
Critical Commercial Assays
Wizard Genomic DNA Purification Kit VWR International, LLC Cat#PAA1120 (EA)
QIAquick PCR Purification Kit (250) QIAGEN, Inc. Cat#28106
NEBuilder HiFi DNA Assembly Master Mix - 10 rxns New England BioLabs Cat#E2621S
QIAGEN Plasmid Mini Kit (100) QIAGEN, Inc. Cat#12123
Quick Ligation Kit New England BioLabs Cat#M2200S
DC Protein Assay Bio-Rad Laboratories Cat#5000116
Dual-Glo Luciferase Assay System Promega Cat#E2920
Quantitative Colorimetric Peptide Assay Fisher Scientific Cat#PI23275
Pierce High pH Reversed-Phase Peptide Fractionation Kit Fisher Scientific Cat#PI84868
Deposited Data
Bacterial Proteomics Data ProteomeXchange PXD015341
Supernatant Proteomics Data ProteomeXchange PXD015342
Spleen Temporal Infection Proteomics Data ProteomeXchange PXD015343
Experimental Models: Cell Lines
THP-1 ATCC Cat#TIB-202
Experimental Models: Organisms/Strains
Mouse: ICR (CD-1) Outbred Mice Envigo RRID:IMSR_CRL:22
Mouse: Ifnar1 −/− in C57BL/6 Background MMRRC 32045-JAX
Oligonucleotides
Primers used in this study are listed in the Table S5 Integrated DNA Technologies, 
Inc.
N/A
Recombinant DNA
pACYC184 Kindly provided by Dr. Victor 
Nizet (UCSD) (Nakano et al., 
1995)
N/A
pHY304 Kindly provided by Dr. Victor 
Nizet (UCSD) (Pritzlaff et al., 
2001)
N/A
pHY304-ess::cat This work N/A
PDCerm Kindly provided by Dr. Victor 
Nizet (UCSD) (Jeng et al., 2003)
N/A
pDCerm::ess This work N/A
N-HisPP-pET-28a(+) Kindly provided by Dr. Partho 
Ghosh (UCSD)(Buffalo et al., 
2016)
N/A
N-HisPP-pET-28(+)::ess This work N/A
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REAGENT or RESOURCE SOURCE IDENTIFIER
pDCerm::ermm1 This work N/A
Software and Algorithms
NEBuilder Assembly Tool New England BioLabs http://nebuilder.neb.com/
BPROM Softberry http://www.softberry.com/
berry.phtml?
topic=bprom&group=programs
&subgroup=gfindb
Promoter Prediction by Neural Network Martin Reese http://www.fruitfly.org/
seq_tools/promoter.html
Clustal Omega Sievers et al., 2011 https://www.ebi.ac.uk/
Tools/msa/clustalo/
PRALINE Simossis and Heringa, 2005 http://ibi.vu.nl/programs/
pralinewww/
Phyre2 Kelley et al., 2015 http://www.sbg.bio.ic.ac.uk/
phyre2/html/page.cgi?id=index
SoftWoRx v5.5.1 Applied Precisionin N/A
FIJI SciJava https://fiji.sc
CellProfiler Kamentsky et al., 2011 https://cellprofiler.org/
Proteome Discover Thermo-Fisher N/A
R Studio RStudio Team (2015). RStudio: 
Integrated Development for R. 
RStudio, Inc., Boston, MA 
URLhttps://rstudio.com/
https://rstudio.com/
fSVA package Parker et al., 2014 N/A
Short Time-series Expression Miner (STEM) Ernst and Bar-Joseph, 2006 http://www.cs.cmu.edu/jernst/
stem/
String-db String Consortium 2019 https://string-db.org/cgi/input.pl
Cytoscape v3.7.1 National Resource for Network 
Biology
https://www.cytoscape.org
GraphPad Prism GraphPad Prism version 7.00 for 
Windows, GraphPad Software, La 
Jolla California USA,https://
www.graphpad.com
https://www.graphpad.com
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